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Abstract 
 
High intensity intermittent training (HIIT) is a time efficient mode of exercise, 
which has been shown to induce metabolic benefits, such as an improvement 
in insulin sensitivity (IS) and thus type 2 diabetes (T2D). Vitamin D3 (25(OH)D3) 
supplementation has also been shown to influence the pathogenesis of IS. The 
aim of this study was to investigate if there is a combined effect of HIIT and 
25(OH)D3 supplementation on IS.  
Twelve inactive and overweight adults (9 male, 3 female; age: 32 ± 18-45 y, 
BMI: 31.9 ± 2.8 kg·m-2) performed HIIT 3 times/week for 6 weeks, with oral 
glucose tolerance tests and peak oxygen consumption (V̇O2peak) tests done at 
baseline and post-intervention. The HIIT protocol consisted of 10 x 1 min 
intervals cycling at 97 ± 8 % V̇O2peak separated by 1 min active recovery. 
Participants were randomised to ingest 4000 IU/day 25(OH)D3 (n=6) or a 
placebo (n=6). Plasma glucose, insulin, 25(OH)D3, adiponectin, leptin, and the 
lipid profile were analysed pre and post training.  
Peak V̇O2 and power output was increased in all participants (P<0.01). Systolic 
blood pressure (BP) was reduced in all participants and the vitamin D group 
(P<0.05) but not the placebo group. Insulin area under the curve (AUC) was 
significantly reduced by 16.6% in the placebo group (P<0.05) but not overall 
for all participants or the vitamin D group. There was no change in fasting 
glucose or glucose AUC. Insulin sensitivity index (ISI) and homeostatic model 
assessment of insulin resistance (HOMA-IR) remained unchanged across all 
groups. All participants were 25(OH)D3 deficient (<20 ng·ml-1) at baseline, with 
an increase in 25(OH)D3 in the vitamin D group after 6 weeks (P<0.05). 
Adiponectin decreased in the placebo group but was unaltered in the vitamin 
D group. Leptin remained unaltered in all groups. Plasma triglycerides were 
reduced in all participants (P<0.05). 
In conclusion, 6 weeks of HIIT increased physical capacity but had no effect 
on the ISI and HOMA-IR in overweight and obese males and females. The 
findings showed that 6 weeks of supplementation resulted in an increase in 
25(OH)D3 and an improvement in systolic BP.   
III 
 
Acknowledgements 
 
First and foremost I wish to thank my supervisor Dr Melanie Leggate for her 
ample time, help and guidance over the year (and the rest). Her support and 
advice has been constant and greatly appreciated, and I have learnt a lot from 
her both academically and in research. I also wish to thank Dr Geraint Florida-
James for his advice and feedback as my secondary supervisor. 
I couldn’t have started or completed data collection without the incredibly 
helpful lab technicians: Russell, Steve and Marina. They have taught me so 
much over the time of my Masters and answered all my many equipment and 
participant related questions. A much deserved thank you also goes to Mark 
Ross who provided not only constant and intellectual advice, but was a calming 
voice and a true friend. 
The time taken by Liam Thomas from Randox Research to teach me analysis 
methods and generously providing us with samples is greatly appreciated, and 
were very valuable to the study. As were the lessons in the lab from Lesley 
Ingram in how to analyse samples via ELISA kits. 
I wish to acknowledge the help in recruitment from City Cabs, The Scout 
Association and Girlguiding Scotland for circulating advertisement and 
information regarding the study. 
One of the most important thanks must go to the participants who gave up their 
time, sweat, and tears. The study couldn’t have been completed without them 
and I appreciate their cooperation, friendly banter, and very varied music 
choices.  
Lastly, I wish to thank my family and friends for their support, primarily from 
the other end of a phone, with my worries, mini break-downs, and stresses. As 
always my mum and dad fully support my choices and career goals, I value 
their patience and life experience greatly. Everyone in the office has been there 
for me through the highs and lows and I couldn’t have kept calm and carried 
on without their profound support! 
  
IV 
 
Contents 
 
Abstract II 
Acknowledgements III 
List of tables VII 
List of figures VIII 
List of abbreviations X 
1.0 Introduction 1 
2.0 Literature review 4 
2.1 Pathophysiological events in Type 2 diabetes 5 
2.2 Obesity and insulin resistance 6 
2.3 Physical activity and insulin sensitivity 9 
2.4 HIIT 10 
2.4.1 HIIT as an alternative to moderate intensity 
continuous training 10 
2.4.2 Metabolic benefits of HIIT 12 
2.4.3 Acute effects of HIIT 13 
2.4.4 Chronic effects and metabolic adaptations to HIIT 14 
2.4.5 Effect of HIIT on adiponectin and leptin 18 
2.5 Vitamin D 18 
2.5.1 Vitamin D metabolism and status 18 
2.5.2 Vitamin D and insulin sensitivity 20 
2.5.3 Vitamin D deficiency and obesity 21 
2.5.4 Vitamin D supplementation 21 
2.5.5 Vitamin D supplementation and insulin sensitivity 23 
2.5.6 Effect of vitamin D supplementation on adiponectin 
and leptin 27 
2.6 Summary 28 
2.7 Aims and hypothesis 29 
3.0 Materials and methods 30 
3.1 Overview of study 31 
V 
 
3.2 Participants and ethical approval 31 
3.3 Control measures 32 
3.4 Visit 1 33 
3.4.1 Anthropometric measurements and blood pressure 33 
3.4.2 Peak oxygen uptake test 33 
3.4.3 Familiarisation trial 34 
3.5 Visit 2 34 
3.5.1 Oral glucose tolerance test 34 
3.6 Visits 3-20 35 
3.6.1 High intensity intermittent training 35 
3.6.2 25(OH)D3 Supplementation 35 
3.7 Visit 21 36 
3.7.1 Post-training OGTT and V̇O2peak test 36 
3.8 Blood sampling 36 
3.9 Blood sample analysis 37 
3.9.1 Enzyme-linked immunosorbent assays (ELISA) 37 
3.9.2 Biochemical analysis 37 
3.9.3 Haematological analysis 37 
3.9.4 Coefficient of variation (CV) 38 
3.9.5 Plasma volume changes (PVC) 38 
3.9.6 Insulin Sensitivity Index (ISI) 38 
3.10 Statistical analysis 39 
4.0 Results 40 
4.1 25-hydroxyvitamin D3 41 
4.2 Exercise outcomes 43 
4.3 Participant characteristics 48 
4.3.1 Physical and metabolic characteristics 48 
4.3.2 Haematological values 50 
4.3.3 PVC 50 
4.4 OGTT outcomes and insulin sensitivity 52 
VI 
 
4.5 Adiponectin and leptin 56 
4.6 Lipids 58 
5.0 Discussion 60 
5.1 Key findings 61 
5.2 Vitamin D status and effect of supplementation 61 
5.3 Cardiovascular benefits of HIIT 63 
5.4 HIIT and vitamin D supplementation on insulin 
sensitivity 64 
5.5 Adiponectin and leptin 66 
5.6 Impact on lipid profile and metabolism 68 
5.7 Adherence to HIIT 68 
5.8 Conclusions 69 
5.9 Issues, limitations, and future research 70 
6.0 References 71 
7.0 Appendices 93 
Appendix 1 A 94 
Appendix 1 B  97 
  
List of tables 
 
Table 1: Baseline participant characteristics 32 
Table 2 CV values for all assays and analysis methods 38 
Table 3: Power output, HR and V̇O2 averaged across all 10 intervals 
in HIIT session 1, 7, and 13. 43 
Table 4: Pre- and post-training values for all participants, the placebo 
group, and the vitamin D group 49 
Table 5: Haematological values for all participants, the placebo 
group, and the vitamin D group pre- and post-training. 51 
Table 6: Pre- and post-training glycaemic indices 55 
Table 7: Blood lipid biomarkers pre- and post-training for all groups 59 
  
VIII 
 
List of figures 
 
Figure 1: The hyperbolic relationship between insulin secretion and 
insulin sensitivity relative to weight/body composition. 
Adapted from Kahn et al. (1993). NGT, normal glucose 
tolerance; IGT, impaired glucose tolerance; T2D, type 2 
diabetes mellitus. 7 
Figure 2: The dose-response relationship between vitamin D 
supplementation and 25(OH)D concentration. Taken from 
Ekwaru et al. (2014): page 4. 26 
Figure 3: The dose-response relationship between vitamin D 
supplementation and 25(OH)D concentration by weight 
status based on BMI category. Taken from Ekwaru et al. 
(2014): page 7. 27 
Figure 4: Schematic diagram of a HIIT session 35 
Figure 5: (A) Pre- and post-training 25(OH)D3 concentration for all 
participants (n=12), the placebo group (n=6), and the 
vitamin D group (n=6); (B) individual changes in 25(OH)D3 
pre- to post-training. *Denotes a main effect of time 
(P<0.05). 42 
Figure 6: The percentage of baseline (A) peak HR and (B) peak V̇O2 
that participants were cycling at during the individual 
intervals in the first, seventh and thirteenth HIIT sessions 
(n=12). 44 
Figure 7: Absolute V̇O2peak (A) and relative V̇O2peak (B) pre- and post-
training for all participants (n=12), the placebo group (n=6), 
and the vitamin D group (n=6). *Denotes a main effect of 
time (P<0.05). 46 
Figure 8: Absolute Wpeak (A) and relative Wpeak (B) pre- and post-
training for all participants (n=12), the placebo group (n=6), 
IX 
 
and vitamin D group (n=6). *Denotes a main effect of time 
(P<0.05). 47 
Figure 9: Plasma glucose (A) and insulin (B) responses to a 75 g 
OGTT pre- and post-training for all participants (n=12). 52 
Figure 10: Plasma glucose (A) and insulin (B) responses to a 75 g 
OGTT pre- and post-training for the placebo group (n=6) 
and the vitamin D group (n=6). 53 
Figure 11: Group and individual changes for adiponectin: (A) 
baseline and post-intervention adiponectin for all 
participants (n=12), the placebo group (n=6), and the 
vitamin D group (n=6); (B) adiponectin individual changes 
(n=12). *Denotes a main effect of time (P<0.05). 56 
Figure 12: Group and individual changes for leptin: (A) baseline and 
post-intervention leptin for all participants (n=12), the 
placebo group (n=6), and the vitamin D group (n=6); (B) 
leptin individual changes (n=12). 57 
  
X 
 
List of abbreviations 
 
ANOVA analysis of variance 
AUC area under the curve 
BMI body mass index 
bmp beats per minute 
DEXA duel-energy X-ray absorptiometry 
dL deciliter 
EDTA ethylenediaminetetraacetic acid 
ELISA enzyme linked immune sorbent assay 
g gram 
h hour 
Hb haemoglobin 
Hct haematocrit 
HDL high density lipoprotein 
HIIT high intensity intermittent training 
HOMA-IR Homeostasis Model Assessment of Insulin 
Resistance 
HR heart rate 
IL interleukin 
ISI Insulin Sensitivity Index 
IU International Units 
kDa kilodaltons 
kg kilogram 
L litre 
LDL low density lipoprotein 
XI 
 
m metre 
min minute 
ml millilitre 
mmol millimole 
ng nanogram 
nmol nanomol 
O2 oxygen 
OGTT oral glucose tolerance test 
PLT platelet 
PVC plasma volume change 
RBC red blood cell 
rpm revolutions per minute 
s second 
SD standard deviation 
T2D type 2 diabetes 
TNF-α tumour necrosis factor – alpha 
V̇O2max maximal oxygen consumption 
V̇O2peak peak oxygen consumption 
W Watt 
w/v weight to volume 
WBC white blood cell 
y years 
% percent 
µg microgram 
µl microliter 
25(OH)D 25-hydroxy vitamin D 
  
 
 
 
 
 
1.0 Introduction 
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Obesity and an inactive lifestyle have been reported to be the leading causes 
of global mortality (WHO, 2010), with a staggering 27% of diabetes cases 
attributed to physical inactivity (Must et al., 1999). The prevalence of type 2 
diabetes (T2D) is rapidly increasing and is expected to increase from 171 
million in the year 2000 to 366 million people in 2030 worldwide (Wild et al., 
2004). The initial pathophysiological event in the development of T2D is 
usually insulin resistance and chronic hyperglycaemia (Kahn, 2003). Diabetes 
costs NHS Scotland £1 billion per annum and thus stresses the importance of 
investing in feasible strategies to improve physical activity levels in Scotland. 
Diabetes cases are also projected to rise by 17% in the next 25 years in 
Scotland alone (Hex et al., 2012), and since the development of T2D is mainly 
attributed to lifestyle choices, the focus should be on preventing T2D through 
increased activity levels and diet. In some cases exercise has also been found 
to be a better form of prevention and treatment than medicine, presenting a 
cost-effective approach (Naci and Ioannidis, 2013). 
The most commonly reported barrier to physical activity and exercise is “lack 
of time” (Stutts, 2002; Trost et al., 2002). High intensity intermittent training 
(HIIT) involves repeated short bouts of exercise at an intensity above 85% of 
maximal capacity, and has been shown to provide similar, and in some cases 
greater, physiological and metabolic adaptations compared to work-matched 
moderate intensity endurance training (Burgomaster et al., 2008; Babraj et al., 
2009; Racil et al., 2013; Little et al., 2014; Mitranun et al., 2014). Currently, the 
UK Government Physical Activity Guidelines for Adults (2011) are based on 
moderate and vigorous intensities but consequently require a commitment 
time of 150 or 75 minutes/week of aerobic exercise, respectively.  
There is also a graded increase in the prevalence of T2D with increasing 
severity of overweight and obesity, therefore individuals with respective body 
mass indices (BMI) of 25-30 kg·m2 and 30-35 kg·m2, should be a target group 
for exercise interventions (Must et al., 1999).  
Supplementation with cholecalciferol (25(OH)D3), known commonly as vitamin 
D3, has been reported to resemble the effects induced by exercise, specifically 
HIIT, on glucose metabolism and insulin sensitivity. The effects have been 
found to be dose and duration dependent, with vitamin D deficiency associated 
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with overweight and obesity (Pittas et al., 2006; Pittas et al., 2007; Gallagher 
et al., 2012; Belenchia et al., 2013; Gallagher et al., 2013). The proposed 
mechanisms underpinning the effect of vitamin D on insulin resistance are the 
reduction of pro-inflammatory markers and enhancing circulating glucose 
homeostasis (Flores, 2005). 
Specifically, adiponectin concentrations have been altered with a strong 
correlation presented. The adiponectin concentration in the circulating blood 
can be reported as a clinical indicator of insulin resistance as it induces insulin-
sensitising properties (Fasshauer et al., 2008). Elevated adiponectin levels can 
predict and indicate lower insulin resistance, therefore supplementing with 
vitamin D has the potential to improve the risk of developing T2D (Lin et al., 
2007).  
There is very little research investigating a combined effect of vitamin D 
supplementation and exercise training, although recent studies have 
suggested that the effect on glucose control is independently regulated by 
increased vitamin D concentration and HIIT (Barker et al., 2013; Kobza et al., 
2013).  
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2.1 Pathophysiological events in Type 2 diabetes 
Type 2 diabetes mellitus refers to a metabolic system collapse when there is 
reduced secretion or a loss of response to endogenous insulin resulting in a 
recurring state of hyperglycaemia (Alberti and Zimmet, 1998). The 
development of T2D has been primarily and extensively reported as relative 
contributions of insulin resistance and beta cell (β cell) dysfunction (Kahn, 
2003). Through genome-wide association studies there is evidence that 
genetic predisposition plays a role in the development of T2D, although only a 
small proportion in comparison to a healthy diet and regular physical activity 
(Ardisson Korat et al., 2014). Additionally, environmental and epidemiological 
factors such as geographical, cultural, and seasonal influences can predispose 
specific population groups to the onset of T2D (Wild et al., 2004), with vitamin 
D deficiency playing a key role (Holick and Chen, 2008).  
Beta cells are unique cells located in the islets of Langerhans in the pancreas 
that store and secrete the hormone insulin - responsible for regulating blood 
glucose concentrations. Beta cells quickly respond to changes and spikes in 
blood glucose concentration through the mediated secretion of insulin 
following activation of the insulin receptors located in the cell membrane 
(Kahn, 2003; Abdul-Ghani et al., 2006). However, if β cell function is impaired 
or β cell mass is reduced the effectiveness of the insulin response to a lower 
glucose concentration and achieve homeostasis becomes diminished 
(Wolden-Kirk et al., 2011). To compensate, the β cells up-regulate the 
production of insulin, which accelerates β cell turnover and thus reduces the 
life span of the cell. It can also result in permanent cell damage. Similarly, if 
hepatic cells become resistant to the insulin that is secreted then glucose 
control can become impaired (Saltiel and Kahn, 2001). It is primarily this 
dysfunctional utilisation of insulin, a reduction in the sensitivity to insulin, which 
can lead to chronic hyperglycaemia: the main physiological event in the 
development of T2D (Kahn, 2003). A breakdown in the cross-talk between the 
pancreatic β cell and peripheral tissue insulin sensitivity results in the 
progressive deterioration of glucose homeostasis (Gastaldelli, 2011).  
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Modifiable lifestyle risk factors such as obesity and low levels of physical 
activity are the main determinants of the metabolic disease in both males and 
females (Tuomilehto, et al., 2001). 
 
2.2 Obesity and insulin resistance 
The critical role of weight and body composition has been identified through 
the consideration of the hyperbolic relationship between β cell insulin secretion 
and insulin sensitivity, illustrated in Figure 1 (Kahn et al., 1993). 
Overweight/obesity and physical inactivity are regarded as the main 
contributors to insulin resistance, with many studies concluding that increased 
subcutaneous fat mass is associated with an increased risk of developing T2D 
(Gastaldelli et al., 2000; Gastaldelli et al., 2002; Snijder et al., 2005; Guh et al., 
2009). Any defects in the insulin signalling cascade can cause the 
development of insulin resistance and impaired glucose tolerance (Saltiel and 
Kahn, 2001; Abdul-Ghani et al., 2006). Subcutaneous and visceral fat 
accumulation can lead to chronic hyperglycaemia primarily due to an 
increased rate of gluconeogenesis resulting in elevated hepatic glucose 
secretion (Gastaldelli et al., 2002; Gastaldelli et al., 2007). Excess abdominal 
and subcutaneous fat is also associated with decreased muscle glucose 
uptake and increased release of free fatty acids (FFAs), which presents a 
hyperglycaemic and lipotoxic state (Gastaldelli, 2011). Systemic 
hypoinsulinemia also advances in the presence of fat accumulation as a result 
of the decreased expression of insulin receptors, which is mediated through 
the transcription process (Kahn et al., 2006). Consequently, hepatic and 
peripheral insulin sensitivity are reduced following the development of impaired 
glucose tolerance through mechanisms associated with obesity. Straying from 
the hyperbolic curve (Figure 1) can result in impaired glucose tolerance and 
subsequently pre-diabetes if both abnormalities exist: insulin resistance and β-
cell dysfunction (Kahn et al., 1993).  
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Figure 1: The hyperbolic relationship between insulin secretion and insulin sensitivity relative 
to weight/body composition. Adapted from Kahn et al. (1993). NGT, normal glucose tolerance; 
IGT, impaired glucose tolerance; T2D, type 2 diabetes mellitus. 
 
Adipose tissue releases numerous hormones and anti- and pro-inflammatory 
cytokines, such as interleukin-6 (IL-6), tumour necrosis factor – alpha (TNF-α), 
which are small proteins of 22 and 17 kilodaltons (kDa) respectively that 
influence insulin and glucose metabolism. However, an abnormal amount of 
fat mass and thus an excess of adipocytes can detrimentally affect insulin 
sensitivity (Kahn et al., 2006). Therefore, the systemic circulation of pro- and 
anti-inflammatory cytokines could act as a predictor of the development or the 
presence of impaired glucose tolerance and thus T2D (Eder et al., 2009). This 
overabundance of adipocytes has been associated with reduced 
concentrations of the adipose tissue-derived protein hormone adiponectin 
(Punthakee et al., 2006), which expresses both anti- and pro-inflammatory 
properties (Ohashi et al., 2012). One of the primary actions of adiponectin is 
to mediate numerous metabolic processes involving insulin regulation and 
action and glycaemic homeostasis (Lihn et al., 2005).  
In the pathogenesis of T2D there is increasing evidence that cytokines and 
associated hormones induce an acute-phase immune response and 
inflammatory reaction that contributes to chronic low-grade inflammation 
(Schmidt et al., 1999; Spranger et al., 2003). The pattern of circulating 
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inflammatory cytokines and other proteins that exhibit pro- and anti-
inflammatory properties can modify the risk for the development of T2D 
(Spranger et al., 2003; Smitka and Maresova, 2015). The association between 
obesity and insulin resistance is partly attributed to a decrease in adiponectin 
and thus an alteration in the pattern of circulating hormones and proteins 
(Hotamisligil et al., 1994; Katergari et al., 2015). Adiponectin has been 
reported to influence secretory intracellular-pathways that are mediated by 
signal transduction from the insulin receptor, with low levels associated with 
insulin resistance (Kadowaki et al., 2006; Punthakee et al., 2006). Reducing 
or preventing low adiponectin concentrations may directly or indirectly 
influence insulin action on cell membrane involved in hepatic and skeletal 
muscle glucose uptake. This has also been shown to be influenced by an 
increase in physical activity and exercise, with exercise intensity altering the 
capacity of muscle to oxidise fat and carbohydrates (Perry et al., 2008; Racil 
et al., 2013; Hansen et al., 2015). Circulating adiponectin concentration may 
thus be a predictor of insulin resistance and inflammation-induced impaired 
glucose tolerance. 
Leptin is a hormone that induces the feeling of satiety and thus can influence 
appetite and weight status (Klok et al., 2007; Deighton et al., 2013; Deighton 
et al., 2014). Leptin is often associated with adiponectin, with an elevation in 
adiponectin-to-leptin ratio reported to correlate with a rise in fasting glucose. 
Although, this may not always be the case as adiponectin expression has been 
reported to have no direct association with plasma concentrations of leptin 
(Kern et al., 2003). Indirect mechanisms may exist but are currently unknown. 
A low concentration of adiponectin has also been negatively associated with 
visceral adiposity and other features of the MetS suggesting reduced systemic 
adiponectin is a predictor for the development of T2D (Hotta et al., 2000). It 
has been demonstrated that an upregulation of adiponectin and leptin can 
induce glucose uptake and thus play a role in insulin regulation and action. 
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2.3 Physical activity and insulin sensitivity 
A physically inactive lifestyle is associated with the development of impaired 
glucose metabolism and pre-diabetes (Sarvas et al., 2015). Physical activity 
has been found to prevent T2D but is dependent on baseline risk of T2D (Gill 
and Cooper, 2008) and thus a range of activities and exercise at different 
intensities should be considered for preventing or delaying the onset of T2D. 
Exercise induces numerous physiological, metabolic, and cardiovascular 
adaptations that are directly linked to a reduction in the risk of developing 
chronic conditions, specifically impaired glucose tolerance (Trapp et al., 2008; 
Babraj et al., 2009; Wisloff et al., 2009; Iellamo et al., 2013). The post-prandial 
insulin response is influenced by physical activity status, with structured 
exercise demanding a relatively higher demand on hepatic and skeletal muscle 
metabolism, which alters the respiratory exchange ratio (RER) value and thus 
substrate availability and utilisation (Thompson et al., 1998; Warren et al., 
2009; Thompson et al., 2012). This efficient insulin control is required to 
regulate systemic glucose concentration in order to meet the increased fuel 
demand during exercise, the fuel source of which is dependent on exercise 
intensity (Marliss and Vranic, 2002). During exercise, the production, 
regulation and uptake of glucose is mediated by the glucose transporter type 
4 (GLUT4) through insulin-controlled pathways (Park et al., 2014), contributing 
to glycogen stores if not metabolically required. Insulin secretion is inhibited 
during exercise and thus relies on hepatic and skeletal muscle tissue cells 
being sufficiently sensitive to insulin to maintain glucose homeostasis. It is now 
well established that the expression and protein content of GLUT4 increases 
following endurance exercise (Kraniou et al., 2004; Hansen et al., 2015). As a 
result, GLUT4 is available for translocation to improve efficiency of skeletal 
muscle glucose uptake through insulin action, subsequently enhancing the 
insulin sensitive capacity of muscle cells (Goodyear and Kahn, 1998). 
Following exercise, the up-regulation of metabolic demand stimulates the role 
of glycogen depletion in mediating improvements in insulin resistance (Jensen 
et al., 2011; Metcalfe et al., 2012). Exercise at higher intensities primarily rely 
on muscle glycogen as the main source of carbohydrate fuel (Romijn et al., 
1993; van Loon et al., 2001). However, 6 weeks of low volume sprint interval 
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training (SIT) in healthy adults (Metcalfe et al., 2012) has been found to induce 
a reduction in the rate of glycogen utilisation, indicating reduced 
glycogenolysis and consequently a reduction in systemic hyperglycaemia 
(Jensen et al., 2011). To accommodate the reduction in glycogenolysis, there 
is a shift in substrate utilisation with an increase in the rate of lipolysis to meet 
and maintain the demand required (Romijn et al., 1993). This induced skeletal 
muscle oxidative capacity remodelling can be caused by a number of exercise-
induced metabolic adaptations, such as: mitochondrial capacity, mitochondrial 
biogenesis, skeletal muscle mass (Little et al., 2011; Hansen et al., 2015).  
 
2.4 HIIT 
 
2.4.1 HIIT as an alternative to moderate intensity continuous training 
It is well established that exercise provides cardiovascular and metabolic 
adaptations that prevent adverse health outcomes such as the development 
of atherosclerosis (Roberts et al., 2002), cardiovascular disease (Warburton et 
al., 2005; Tjonna et al., 2008; Tjonna et al., 2009), and T2D (Knowler et al., 
2002; Bassuk and Manson, 2005; Stanford and Goodyear, 2014). Despite the 
general consensus that exercise induces responses and adaptations that 
improve insulin sensitivity, morphological and metabolic adaptations 
differentiate between different modes and intensities of exercise training 
(Wisloff et al., 2007; Iellamo et al., 2013).  
Moderate intensity exercise involves a relatively large volume of continuous 
aerobic exercise (50-75 % V̇O2peak), high intensity intermittent training (HIIT) 
involves repeated short bouts, ranging from 5 s to 4 min long, at a constant load 
(75-100 % V̇O2peak) interspersed with active or passive recovery periods, and 
SIT involves ‘all-out’ sprints (≥100 % V̇O2peak) also separated with rest or active 
recovery periods.  
High intensity intermittent training has garnered attention in recent years in a 
more general and clinical application as it has been found to promote 
adaptations that are often similar or superior to moderate intensity continuous 
training (Wisloff et al., 2007; Tjonna et al., 2008; Iellamo et al., 2013; Racil et al., 
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2013; Trombold et al., 2013; Mitranun et al., 2014; Jung et al., 2015). Commonly, 
HIIT has been used in athletic populations for years by coaches to provide 
molecular adaptations to better performance outcomes. However, more recently 
HIIT has been established as a method for health-associated adaptations that 
are similar or in some cases greater than moderate intensity training, with scope 
for considerably shorter commitment time required from individuals. The most 
common reported barrier to physical activity and exercise is “lack of time” 
(Stutts, 2002; Trost et al., 2002). Short sprints and minimal interspersed 
recovery periods comprising HIIT protocols can reduce the commitment time 
per session, to as little as 10 minutes (Gillen et al., 2014), presenting a time 
efficient mode of exercise and overcome adherence issues (Jung et al., 2015). 
Accumulating evidence has shown that HIIT can improve insulin sensitivity in 
individuals at risk of developing T2D (Trapp et al., 2008; Babraj et al., 2009; 
Richards et al., 2010; Metcalfe et al., 2012; Iellamo et al., 2013; Racil et al., 
2013; Whyte et al., 2013; Mitranun et al., 2014). Although, not all HIIT studies 
have demonstrated changes in all associated indices that contribute to insulin 
sensitivity. Despite an improvement in insulin sensitivity, some HIIT studies 
have observed no changes in fasting insulin (Babraj et al., 2009; Shaban et 
al., 2014), or no effect on fasting glucose or control (Talanian et al., 2007; 
Whyte et al., 2010; Racil et al., 2013).  
There is great variation in the protocols utilised in studies investigating the 
effects of HIIT, with sessions ranging from as low as 3 minutes (Gillen et al., 
2014) up to 1 hour in total (Talanian et al., 2007). Recently, research by three 
research groups has focused on a 2 week intervention involving 8-10 sets of 
60 s bouts on a cycle ergometer at ~90% V̇O2peak or maximum heart rate 
(HRmax), interspersed with 60-120 s rest or cycling at a low intensity (Little et 
al., 2010; Little et al., 2011; Gillen et al., 2012; Little et al., 2014). The latter 
research involved overweight and obese participants, some with diagnosed 
T2D, and has reported improvements in insulin sensitivity, changes in glucose 
uptake through the action of GLUT4, decreases in glucose area under the 
curve (AUC), and alterations in metabolism, such as an increase in resting 
muscle glycogen. 
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A number of studies have utilised SIT interventions involving ‘all-out’ sprints 
ranging from 6 s (Adamson et al., 2014), 10-20 s (Metcalfe et al., 2012), and 
up to 30 s (Burgomaster et al., 2005; Babraj et al., 2009; Richards et al., 2010; 
Racil et al., 2013). Despite the improvements in insulin sensitivity gained from 
very intense protocols, the nature of the intervals, i.e. the intensity involved, 
may be discouraging to a population that is not accustomed to regular 
exercise. Therefore, more suitable protocols involving longer bouts but slightly 
lower intensities can be used to accommodate such population groups or 
provide an alternative to increase adherence. Adherence to exercise is low in 
individuals at risk of pre-diabetes (Jung et al., 2014; Jung et al., 2015), 
however there is preliminary evidence that individuals at risk of pre-diabetes 
can adhere to HIIT, 10 x 1 min at ~90 % of peak heart rate (HRpeak), as a time-
efficient form of exercise more so than continuous moderate intensity exercise, 
50 min at ~65 % HRpeak (Jung et al., 2014; Jung et al., 2015). 
The interspersed recovery intervals should be determined based on the 
intensity and duration of the high intensity exercise bouts, allowing for full or 
partial recovery (Bompa, 1999). Also, depending on the length of the study 
intervention, periodisation in training should be adopted in order to increase 
the intensity/work load in line with correlated increases in peak physical 
capacity and skeletal muscle metabolic capacity. This allows for physiological 
and metabolic adaptations to occur before increasing the work load (Bompa, 
1999).  
 
2.4.2 Metabolic benefits of HIIT 
Since HIIT is designed to implement a higher workload and power output 
compared to continuous moderate intensity exercise, the cardiovascular and 
metabolic systems respond accordingly to tolerate the demand (Romijn et al., 
1993; Laursen and Jenkins, 2002; Gibala et al., 2012). The high stimulus effect 
of HIIT can further up-regulate the uptake of glucose to contracting muscles 
and the liver when compared to moderate or low intensity training. As a result, 
HIIT has been found to have the potential to augment the effective regulation 
and action of insulin through direct and indirect pathways (Kemmler et al., 
2015).  
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2.4.3 Acute effects of HIIT 
During a single session of HIIT, HR has been reported to increase rapidly with 
time, and intermittently with each interval reference. The HR response to short 
(8 s bouts with 12 s recovery) and long (24 s bouts with 36 s recovery) ‘all-out’ 
intervals has been investigated in young women, reporting HR to increase to 
near maximal (calculated as 220 minus age) following 2 bouts (Trapp et al., 
2007). The increase in HR coincides with the number of intervals completed, 
with the long sprints generating a greater power output. In addition, Trapp et 
al. (2007) found epinephrine and norepinephrine to be significantly elevated 
post-exercise, suggesting that β-adrenergic receptor sensitivity in adipose 
tissue may be enhanced, therefore causing a drive in lipolysis. Essentially, 
HIIT can benefit the overweight and obese population due to an increase in fat 
oxidation and lipolysis, and fat loss (Talanian et al., 2007; Trapp et al., 2008; 
Mitranun et al., 2014).  
Acute HIIT studies have demonstrated changes and improvements in 
glycaemia and insulin sensitivity (Gillen et al., 2012; Whyte et al., 2013; Little 
et al., 2014). In a 2 day trial, 4 x 30 s Wingate trials: standard all-out anaerobic 
sprint protocol (Bar-Or, 1987; Vandewalle et al., 1987), were compared to a 
single 200 s (198 ± 10 s) sprint, matched for workload, in overweight/obese 
sedentary men. The extended interval improved insulin sensitivity index by 
44.6 % and decreased insulin resistance (HOMA-IR) by 32 % compared to the 
control group (Whyte et al., 2013). However, both protocols demonstrated no 
change in glycaemia, observed through glucose AUC following an oral glucose 
tolerance test (OGTT). Whyte and colleagues (2012) also investigated the 
effect of a 2 week intervention using the same protocol on the same population 
group, and found repeated Wingates to reduce insulin AUC and decrease 
fasting plasma insulin. Similarly, they reported no effect on glucose 
homeostasis.  
Following a single session of HIIT involving a commonly utilised protocol of 10 
x 60 s constant load bouts at 85 % HRmax, the duration spent in a 
hyperglycaemic state was reduced by 65 % in the 24 h post-training (Gillen et 
al., 2012). Glucose AUC was also reduced, which concurs with other studies 
involving 60 s intervals, whereby a decrease in post-prandial glucose AUC was 
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reported (Little et al., 2014). No effect was found following continuous 
moderate intensity exercise, highlighting the comparable high stimulus effect 
of HIIT on the regulation of insulin and glucose. The volume of high intensity 
exercise within each session may be accountable for the improvements in 
insulin sensitivity and glycaemic control as opposed to the intensity. Following 
a single session of HIIT there have been marked improvements in glucose 
tolerance compared to continuous moderate intensity exercise (Whyte et al., 
2010; Gillen et al., 2012; Little et al., 2014). Although, these may not be 
represented in the long term or induce physiological and metabolic adaptations 
that reduce the development of chronic hyperglycaemia. 
 
2.4.4 Chronic effects and metabolic adaptations to HIIT 
There has been an abundance of studies focusing on 2 week HIIT 
interventions that induce adaptations including increased V̇O2peak, skeletal 
muscle adaptations, and reduced insulin resistance particularly in overweight 
and obese individuals (Burgomaster et al., 2005; Babraj et al., 2009; Little et 
al., 2010; Richards et al., 2010; Whyte et al., 2010; Little et al., 2011). In a 
study involving healthy men with a normal BMI, 2 weeks of HIIT involving 4-6 
Wingates observed no changes in fasting insulin or glucose concentrations 
(Babraj et al., 2009). However, the AUC for both plasma glucose and insulin 
after a 75 g OGTT was reduced by 12 % and 37 %, respectively and insulin 
sensitivity was improved by 16.7 %. These results, along with a similar study 
involving 4-7 Wingates (Richards et al., 2010) that has found an improvement 
in insulin sensitivity, suggest a training-induced adaptation in the insulin 
response even in those with normal glucose tolerance. It should be noted that 
these results were achieved with no change in body mass and an increase in 
calorie consumption. In a population with normal glucose tolerance and thus a 
normal response to a glucose tolerance test, i.e. an OGTT, observing no 
change in glucose homeostasis could indicate that a reduction in fasting insulin 
concentration can occur independently. Whyte et al. (2010) reported a protocol 
involving 4-6 Wingates reduced fasting plasma insulin by 25 % and insulin 
AUC by 15 % in overweight/obese males after just 2 weeks. Another study 
adopting a similar protocol but in obese males and females with T2D, 
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demonstrated a decrease in plasma glucose accompanied with a reduction in 
the HOMA-IR index (Shaban et al., 2014).  
Skeletal muscle is the primary tissue involved in the uptake of post-prandial 
glucose (Baron et al., 1988), suggesting that an increase in muscle activity will 
elevate muscle glucose uptake during exercise. This is reflected in the pre- 
and post-HIIT response of glucose and insulin to an OGTT. The rate limiting 
step in glucose uptake and a contributor to insulin action is the bioavailability 
of GLUT4. HIIT has been shown to be a stimulus for increasing skeletal muscle 
mitochondrial activity through a reported increase in the protein content of 
GLUT4 by 119 % following 2 weeks of HIIT involving 8-12 x 60 s intervals in 
healthy males (Little et al., 2010). Elevated GLUT4 protein content has also 
been accompanied by an improvement in insulin sensitivity in overweight 
adults by ~35 % following a similar protocol (Hood et al., 2011). It may be 
concluded that the intra-cellular translocation of GLUT4 may be stimulated by 
insulin and be a determinant of insulin sensitivity (Park et al., 2014). Muscle 
glucose uptake may also increase due to the higher skeletal muscle oxidative 
capacity and thus muscle fibre recruitment associated with the higher intensity 
workloads and physiological demand that is achieved through HIIT (Little et 
al., 2011). 
Glycogen stores deplete during exercise in order to meet substrate demand 
particularly when intensities are >70 % V̇O2peak (Romijn et al., 1993; van Loon 
et al., 2001). The greater proportion of muscle fibres that need to replenish 
glycogen stores post-HIIT compared to post-moderate intensity training 
increases the demand for glucose uptake to skeletal muscle cells. In turn, this 
induces the requirement of GLUT4 translocation and availability. High intensity 
interval training has been shown to increase glycogen breakdown to a greater 
extent than moderate intensity continuous training and thus allows for effective 
post-prandial storage of glucose, reducing hyperglycaemia, preventing a 
reduction in insulin resistance (Jensen et al., 2011). Resting muscle glycogen 
stores have been shown to increase by as much as 17 % and 26 % in healthy 
adults following 2 weeks of HIIT (Burgomaster et al., 2005; Little et al., 2010). 
Burgomaster et al. (2005) demonstrated that only 2 weeks of HIIT involving 4-
7 x 30 s sprints can increase muscle oxidative capacity. This has been 
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demonstrated through an increase in the maximal activity and protein content 
of citrate synthase: the ‘pace-making enzyme’ involved in glycolysis, which 
stimulates the rate of glucose production and subsequently availability. 
Furthermore, Little et al. (2010) utilised 8-12 longer bouts of 60s and also found 
an increase in muscle glycogen. Although this increase was slightly less than 
that reported by Burgomaster and colleagues (2005), they also reported an 
increase in the protein content of GLUT4 after the same 2 week training period. 
It could be concluded that the intensity and not volume of interval training is 
the main determinant to augment metabolic adaptations. 
When the common 10 x 60 s HIIT protocol was applied to an overweight/obese 
and T2D population, glycaemia was reduced over a 24 h period with an 
accompanying decrease in blood glucose AUC (Little et al., 2011). This 
improvement in the ability to tolerate glucose concentrations assumes an 
effect on insulin sensitivity is possible, although this was not observed. Such 
metabolic adaptations to short-term intervention studies can reduce the risk of 
developing inactivity-related disorders, such as T2D. However, the latter 
protocol has not yet been investigated in overweight and obese adults free of 
diabetes, or in training interventions exceeding 2 weeks. 
Another metabolic adaptation following HIIT is an increase in lipid oxidation. 
Whole body and skeletal muscle capacity for fatty acid oxidation has been 
shown to increase following HIIT. Longer intervals, 10 x 4 min at 90 % of 
V̇O2peak, have demonstrated increased fatty acid oxidation but unchanged 
whole body glucose, despite an increase in maximal muscle citrate synthase 
activity (Talanian et al., 2007). This may predict enhanced insulin utilisation 
due to the more effective control of insulin-mediated glucose regulation to 
achieve homeostasis. It should be taken into consideration that this study 
involved healthy, recreationally active females with normal glucose tolerance. 
In overweight and obese males, 2 weeks of HIIT utilising a similar protocol of 
10 x 4 min at 85 % V̇O2peak observed a beneficial change in the resting 
inflammatory profile but no improvement in insulin sensitivity or glycaemic 
control (Leggate et al., 2012). A reduction in the enzyme fatty acid synthase 
(FAS) was reported following the 2 weeks of HIIT providing further evidence 
for increased fatty acid oxidation after exposure to regular exercise (Tjonna et 
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al., 2008). Despite no reduction in body mass, which has been found as a 
result of HIIT training in other studies (Tjonna et al., 2008), the study by 
Leggate et al. (2012) observed a decrease in waist circumference. Longer 
interventions have been recommended in order to investigate if greater or 
differential benefits in insulin sensitivity, fatty acid oxidation, or changes in 
body composition can be gained through HIIT.  
Longer HIIT intervention studies involving 6-12 weeks of training have reported 
beneficial alterations in glycaemic control in overweight/obese and healthy 
adults (Metcalfe et al., 2012; Adamson et al., 2014). An intervention consisting 
of extremely short cycling sprints, 10 x 6 s, reduced glucose AUC in overweight 
males and females by 6 % (Adamson et al., 2014). Contrastingly, Metcalfe et 
al. (2012) found an increase in glucose AUC following 6 weeks of low-volume 
HIIT: 2 x 10-20 s sprints, though this was only found in healthy but sedentary 
females. Interestingly, the authors also reported a 28 % improvement in insulin 
sensitivity in males but no change in females. This demonstrates that 
beneficial adaptations can be observed despite the relatively low volume of 
training per session, and indicates gender difference may exist in response to 
HIIT. In light of the results, it can be concluded that 6-12 weeks of HIIT may 
be sufficient to induce alterations in the glycaemic profile and thus have the 
potential to improve insulin sensitivity. 
A reduction in insulin resistance also reflects insulin sensitivity and has been 
reported following 12 weeks of HIIT in overweight/obese populations both with 
and without the presence of T2D (Racil et al., 2013; Mitranun et al., 2014). In 
overweight and obese males and females with T2D, a HIIT protocol involving 
4-6 x 60 s at 80-85 % V̇O2peak elicited a reduction in insulin resistance (HOMA-
IR) that was accompanied with a reduction in fasting plasma glucose by 14 % 
(Mitranun et al., 2014). This demonstrates the benefits of HIIT in a population 
already exhibiting the pathophysiological events of T2D. A reduction in insulin 
resistance (HOMA-IR) in obese females without diabetes has also been 
reported following 12 weeks of 6 Wingates per session, however despite the 
reduction in fasting plasma insulin, there was no change in glucose regulation 
(Racil et al., 2013). It appears that the frequent HIIT induces chronic 
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physiological and cardiovascular adaptations that can ultimately improve 
insulin sensitivity and related glycaemic indices.  
 
2.4.5 Effect of HIIT on adiponectin and leptin 
Exercise, specifically HIIT, has been demonstrated to elevate adiponectin 
concentration. Following 12 weeks of HIIT involving 2 series of 6 Wingates, 
adiponectin was increased by 25 % in overweight and obese young females 
(Racil et al., 2013). This was accompanied by a 30 % improvement in insulin 
resistance and a reduction in blood insulin concentration, however no change 
in systemic glucose was observed. Interestingly, HIIT was more effective in 
elevating adiponectin concentration (7.4 ± 1.5 µg·ml-1 to 9.9 ± 1.5 µg·ml-1; 
n=11) than continuous moderate intensity exercise (6.7 µg·ml-1 ± 7.7 µg·ml-1; 
n=11). It should be noted that the change in adiponectin was in parallel to a 
reduction in body mass. Contrastingly, lower adiponectin concentration has 
been reported following 2 weeks of HIIT involving longer 4 min high intensity 
intervals in overweight and obese males (Leggate et al., 2012). However, 
different isoforms of adiponectin exist and since the hormone displays both 
pro- and anti-inflammatory properties through the up and down regulation of 
specific proteins and hormones, this may explain the inconsistency in the 
literature. In addition, the length of HIIT interventions utilised in published 
literature varies substantially, and as a result, the influence on adiponectin and 
leptin concentrations will differentiate between short and long term responses 
reported.  
 
2.5 Vitamin D 
 
2.5.1 Vitamin D metabolism and status 
Vitamin D deficiency (25(OH)D3 <20 ng·ml-1) has been associated with 
reduced insulin sensitivity (Pittas et al., 2006; Pittas et al., 2007; Wolden-Kirk 
et al., 2011). Vitamin D is classified as an active pre-hormone in the body and 
not technically a vitamin as it must be converted into the active form 
(25(OH)D3) from 7-dehydrocholesterol via two consecutive hydroxylation 
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reactions before being biologically and metabolically available to bind to target 
tissues to subsequently elicit intracellular effects (Kumar, 1984). The main 
source of 25(OH)D3 is through skin exposure to Ultra Violet (UV) B rays of a 
specific wavelength (290-315 nm) amounting to approximately 80 % of total 
vitamin D status (Holick, 2002). However, despite being primarily dependant 
on sun exposure, vitamin D3 can also be ingested through the diet from 
sources such as lean meats, poultry, beans, eggs and fatty fish, amounting to 
the remaining 20 % (Holick, 2002, 2009; Zhang and Naughton, 2010). Since 
the formation of 25(OH)D3 only occurs when sun rays of a specific intensity 
directly project onto the skin; this gives rise to seasonal and geographical 
variances: “sun effect” and the “latitude effect” (MacLaughlin et al., 1982; 
Chapuy et al., 1997).  
It has been estimated through studies investigating the prevalence of vitamin 
D deficiency and vitamin D status that 30 – 50 % of all children and adults 
worldwide have established vitamin D deficiency or are at risk (Holick and 
Chen, 2008). The prevalence of vitamin D deficiency has been reported to be 
high, particularly in the winter and spring months, in England and Britain as a 
whole (Hypponen and Power, 2007; Hirani, 2013). The study by Hypponen 
and Power (2007) included men and women from the 1958 British birth cohort, 
all aged 45 years old and were born in England, Scotland or Wales. In the 
latter study almost all of the participants were vitamin D deficient despite the 
seasonal effect: serum 25(OH)D concentrations peaked in September and 
were at their lowest in February. Furthermore, Scotland had significantly lower 
concentrations compared to the other areas of Britain in the summer and 
autumn months (35.4 nmol·L-1 compared to 40.6-42.6 nmol·L-1) and the winter 
and spring months (50.9 nmol·L-1 compared to 60.4-62.4 nmol·L-1). Hirani et 
al. (2013) reported the prevalence of vitamin D insufficiency and deficiency in 
men and women aged 65 years and older in England to be 33.8 % and 51.7 
%, indicating only 14.5 % exhibit a sufficient status. A study evaluating the 
vitamin D status of men and women in Scotland reported a high prevalence of 
deficiency, with a mean 25(OH)D concentration of 35.9 ± 22.5 nmol·L-1 (Zgaga 
et al., 2011). This highlights the importance of interventions, primarily 
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supplementation and/or dietary, aimed at increasing the vitamin D status of 
many populations.  
Epidemiological studies have shown that vitamin D deficiency is associated 
with a higher prevalence of T2D (Pittas et al., 2006) and the development of 
MetS (Barchetta et al., 2013). Therefore, it is crucial to maintain an adequate 
vitamin D status, however supplementation is presented as a safe alternative 
to UV light exposure, which is deemed as unsafe by the Institute of Medicine 
(IOM, 2010). In overweight and obese individuals, lower 25(OH)D3 
concentrations have been reported in individuals with the presence of MetS 
compared to those not affected by MetS, this was independent from the 
presence of T2D (Barchetta et al., 2013). The condition MetS involves a 
combination of at least three of five or six medical conditions that are 
associated with one another: abdominal obesity, physical inactivity/sedentary 
lifestyle, hypertension, hyperglycemia, elevated plasma or serum triglycerides, 
and low high-density lipoprotein (HDL) concentrations. 
 
2.5.2 Vitamin D and insulin sensitivity 
Vitamin D has also been demonstrated to have a functional role in the 
improvement of glucose tolerance through decreases in mean fasting glucose 
in those with and without T2D (Salehpour et al., 2013; Talaei et al., 2013). 
Many studies have shown that increased vitamin D concentration, induced by 
supplementation, can improve fasting plasma insulin and insulin resistance in 
overweight/obese males and females, with or without T2D and vitamin D 
deficiency (von Hurst et al., 2010; Nazarian et al., 2011; Harris et al., 2012; 
Belenchia et al., 2013; Talaei et al., 2013).  
There are several mechanisms underpinning the insulin-sensitising action of 
vitamin D. Hypovitaminosis D has been associated with impaired β-cell 
function (Pittas et al., 2007), chronic low-grade inflammation, and a decrease 
in parathyroid hormone (PTH) concentration (Harris et al., 2012). Even after 
adjusting for weight loss, dietary changes and increased physical activity, a 
higher 25(OH)D3 concentration may reduce the risk of developing T2D (Pittas 
et al., 2012). A direct effect of vitamin D may be through the binding of 
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25(OH)D3 to the vitamin D receptors (VDR’s) found on β-cells and activating 
intra-cellular signalling pathways (Guo et al., 2013), involved in transcriptional 
activation of the human insulin gene and thus up-regulation of insulin 
production and secretion (Maestro et al., 2002).  
 
2.5.3 Vitamin D deficiency and obesity 
The effect of excess fat accumulation on 25(OH)D3 is often overlooked, 
however has been found to be a major biological determinant of vitamin D 
deficiency (Bolland et al., 2007). Vitamin D deficiency is categorised as a 
concentration of <20 ng·ml-1 of 25(OH)D, insufficient concentrations are 
between 21-29 ng·ml-1 and sufficient concentrations are above 30 ng·ml-1 
(Holick et al., 2011). Vitamin D sufficiency is associated with beneficial 
alterations in the treatment and pathogenesis of several chronic health 
conditions, such as hypertension, multiple sclerosis, osteoporosis, and 
diabetes (Holick, 2009; Zhang and Naughton, 2010). The association between 
vitamin D concentration and fat mass is due to the sequestering of fat-soluble 
vitamin D, thereby reducing the bioavailability of systemic vitamin D 
(Wortsman et al., 2000). This uptake of vitamin D by adipocytes renders the 
body as a whole deprived of vitamin D if there is an imbalance between the 
rate of sequestering vitamin D and the rate of 25(OH)D3 synthesis. A strong 
causal relationship occurs in the effect of fat mass on 25(OH)D3 
concentrations, with each 1 kg difference in body mass inducing a deficit 
change in 25(OH)D3 concentration (Bolland et al., 2007).  
 
2.5.4 Vitamin D supplementation 
It is suggested that maintaining an adequate vitamin D status can be achieved 
through daily supplementation (Holick et al., 2011). The IOM recommends a 
daily dietary intake of 600-800 International Units (IU) per day (IOM 2010). 
Note that 100 IU of vitamin D is equivalent to 100 µg. Similarly, the US 
Endocrine Society Guidelines recommend a daily intake of at least 600-800 
IU/day for adults aged 19-50 years (Holick et al., 2011). However, greater 
intake is necessary to replete vitamin D concentrations and counteract 
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insufficiency particularly in a population group that may be at risk of inefficient 
utilisation of ingested vitamin D, i.e. the obese (Ekwaru et al., 2014). Excess 
adipose tissue in overweight/obese individuals exhibits unfavourable 
sequestering of 25(OH)D, therefore posing a need for increased consumption 
via supplementation. Intervention studies have supplemented with a vast 
variation in dosage from 400-10,000 IU/day. Ideally supplementation should 
be population-specific and prescribed based on the current vitamin D status 
and characteristics of the individual: i.e. geographical location, presence of 
T2D, or overweight/obese. However, generally baseline vitamin D 
concentrations are not known prior to supplementation. It is primarily central 
subcutaneous and visceral fat accumulation that affects the bioavailability of 
systemic 25(OH)D (Wamberg et al., 2013). 
Vitamin D can be supplemented in two forms: vitamin D2 known as 
ergocalciferol, and vitamin D3 known as cholecalciferol. The two forms should 
not be used interchangeably as they do not have equal nutritional values. It 
has been reported that vitamin D3 supplementation increases serum 25(OH)D 
concentration more effectively than vitamin D2, by as much as 70 % more 
(Trang et al., 1998). Three months of vitamin D3 supplementation has been 
shown to raise serum 25(OH)D more than vitamin D2, indicating an effective 
response to vitamin D3 (Nimitphong et al., 2013). However, it should be noted 
that the dosage was only 400 IU/day and fasting 25(OH)D concentration did 
not exceed 30 ng·ml-1 (sufficiency) indicating dose of supplementation is 
important.  
The IOM have recommended an upper level intake of 4000 IU/day to prevent 
any associated harm or risk from potentially excessive or high vitamin D 
consumption (Jones, 2008). The Endocrine Society suggest that a daily dose 
of 1500-2000 IU/day or more may be required to elevate circulating 25(OH)D 
concentration above 30 ng·ml-1. They also suggest a dose of 10,000 IU/day 
may be required to correct vitamin D deficiency; however this dose is 
substantially higher than the upper intake limit issued by the IOM (2010). The 
differences between set guidelines and recommendations should be noted and 
taken into consideration when establishing a supplementation dose. Doses 
should also be prescribed on a population-specific basis. 
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2.5.5 Vitamin D supplementation and insulin sensitivity 
There are numerous methodological variations in studies investigating the 
effects of vitamin D supplementation on glucose tolerance, insulin sensitivity 
and hormones involved in metabolism such as adiponectin. For example, the 
length of supplementation and the dose varies between interventions with the 
majority of studies involving overweight and obese male and females, some 
with diagnosed T2D. Doses of 1000 IU/day for 12 weeks in overweight/obese 
females free of diabetes increased 25(OH)D3 concentration by 51 % 
(Salehpour et al., 2013). Similarly, 12 months of this dose elevated 25(OH)D3 
concentration by 31 % in overweight adults with T2D (Breslavsky et al., 2013). 
However, the latter study reported vitamin D status to remain deficient after 
the 12 months, suggesting established insulin resistance may be a 
determinant of low 25(OH)D3 status.  
There are few studies that demonstrate changes in glycaemic control post-
supplementation but a reduction in fasting plasma glucose has been reported 
in two studies by 6.4 % and 5 %, respectively (Salehpour et al., 2013; Talaei 
et al., 2013). Talaei et al. (2013) supplemented males and females with T2D 
with relatively high supplementation dose of 50,000 IU/week, equivalent to 
7142 IU/day over the course of 8 weeks. Whereas, Salehpour et al. (2013) 
provided a much lower dose of 1000 IU/day to overweight and obese females 
over 12 weeks and found a similar result in fasting glucose. The most common 
supplement doses are 2000 IU or 4000 IU/day, with studies supplementing 
with these doses for periods of 12-24 weeks. The lower 2000 IU/day dose has 
been found to increase vitamin D concentration by 19 % in obese adolescents 
after 12 weeks (Nader et al., 2014), 25 % in overweight/obese adults with pre-
diabetes after 16 weeks (Mitri et al., 2011), and 64 % in adults with T2D after 
24 weeks (Ryu et al., 2014). These studies observed no change in fasting 
insulin, insulin sensitivity, or glycaemia but reported sufficient 25(OH)D3 status 
(>30 ng·ml-1) following supplementation. Vitamin D3 was also increased in 
obese adolescents after 12 weeks with no change in insulin sensitivity in the 
2000 IU/day group but not the 400 IU/day group (Javed et al., 2015). 
Interestingly, a higher dose of 4000 IU/day for 12 weeks in African Americans 
with pre- or early–diabetes has been demonstrated to increase insulin 
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secretion, and although insulin sensitivity was reduced following 
supplementation, the decline was only 4 % compared to 12 % observed in the 
control group (Harris et al., 2012). However, the vitamin D concentration was 
sufficient at baseline (39 ng·ml-1) in both groups and thus the comparably lower 
reduction in insulin resistance observed after 12 weeks supplementation may 
be attributed to the substantial rise in concentration to 81.1 ng·ml-1. The vitamin 
D status of the placebo group remained unchanged. Additionally, the 
difference between week 6 and 12 was minimal in comparison to the overall 
increase in concentration, suggesting there may be a plateau in the dose-
response relationship depending on current blood vitamin D concentrations. 
Six month interventions involving 4000 IU/day have also demonstrated 
increases in 25(OH)D3 concentrations by 50 % and 72 %, accompanied with 
improvements in insulin resistance (von Hurst et al., 2010; Belenchia et al., 
2013). Belenchia and colleagues (2013) investigated obese adolescents and 
observed a greater reduction in fasting plasma insulin than the overweight 
middle-aged female population included in von Hurst et al. (2010) study: 28.1 
% compared to 15 %. The baseline 25(OH)D3 concentrations were 
considerably lower in the adults since they had declared vitamin D deficiency 
and it was claimed that insulin resistance improved when 25(OH)D3 
concentrations reached 32 ng·ml-1. This falls in line with the hypothesis that 
insulin sensitivity is improved when the body enters and remains in a vitamin 
D sufficient status.  
Higher doses designed to achieve serum 25(OH)D3 concentrations of ≥30 
ng·ml-1 have controversially observed no changes in glucose or insulin 
concentrations, despite the long intervention lengths of 12 months and 26 
weeks (Davidson et al., 2013; Wamberg et al., 2013). Supplementing with a 
weekly dose of ≥64,731 IU rapidly increased 25(OH)D3 concentrations but did 
not have an effect on insulin secretion or insulin sensitivity in individuals with 
pre-diabetes (Davidson et al., 2013). Following 26 weeks of supplementation, 
elevated vitamin D concentrations had no effect on glucose or insulin 
concentrations in deficient obese adults, again this is despite a high 
supplementation dose of 7000 IU/day (Wamberg et al., 2013). In contrast, a 4 
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week intervention involving a high dose of 10,000 IU/day increased insulin 
sensitivity by 37 % and reduced the acute insulin response to glucose 
(Nazarian et al., 2011). Supplementation with 5000 IU/day for 12 weeks has 
also been found to effectively increase vitamin D concentrations from deficient 
to sufficient and was associated with a significant improvement in β-cell activity 
and a tendency for improvement in insulin resistance, although not statistically 
significant (Al-Sofiani et al., 2015). Improved β-cell function and activity can 
potentially reduce the risk of developing T2D, however a change in insulin 
sensitivity is usually parallel to reduce or prevent hyperglycaemia. 
Furthermore, this may only apply to those with T2D, whereas in those free of 
diabetes, elevating vitamin D concentrations and improving β-cell function and 
insulin sensitivity may prevent the development of pre-T2D. 
Studies focussing on the dose-response relationship of 25(OH)D3 
supplementation found a significant interaction between dose and time with a 
linear relationship observed (Gallagher et al., 2012; Gallagher et al., 2013). 
The elevated concentration in the obese older adults after 6 months was not 
significantly different to that found after 12 months for all doses (400-4800 
IU/day) (Gallagher et al., 2012). This assumes that once 25(OH)D3 
concentrations reach a certain threshold, supplementation can be reduced to 
a dose that will maintain vitamin D sufficiency and ameliorate unnecessary 
over-consumption of the pre-hormone.  
It is hypothesised that obesity is a determinant of vitamin D deficiency and 
supplementation has been shown to overcome this (Belenchia et al., 2013). It 
has been found that the dose-response relationship between vitamin D 
supplementation and 25(OH)D concentrations follows an exponential curve 
(Figure 2), and the relationship between vitamin D supplementation and body 
mass has a curvi-linear response (Figure 3) (Ekwaru et al., 2014). Weight 
status induces a substantial influence on 25(OH)D3 concentrations and thus 
justifies the modification of supplementation dose for overweight and obese 
individuals. Recommendations for vitamin D intake by the IOM do not take into 
consideration the dose-response with regards to weight/BMI, however the 
Endocrine Society acknowledge body mass differentials and recommend 
higher doses for overweight and obesity to achieve sufficiency, concurring with 
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many studies (Gallagher et al., 2012; Choi et al., 2013; Gallagher et al., 2013; 
Zittermann et al., 2014).  
 
Figure 2: The dose-response relationship between vitamin D supplementation and 25(OH)D 
concentration. Taken from Ekwaru et al. (2014): page 4. 
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Figure 3: The dose-response relationship between vitamin D supplementation and 25(OH)D 
concentration by weight status based on BMI category. Taken from Ekwaru et al. (2014): page 
7. 
 
2.5.6 Effect of vitamin D supplementation on adiponectin and leptin 
Elevated vitamin D concentration has been associated with increases in 
adiponectin. In adults with features of MetS, systemic adiponectin was 
increased by 21 % after 12 months of supplementation with 1000 IU/day, 
however no change in insulin resistance was observed (Breslavsky et al., 
2013). An inverse correlation has been reported between insulin sensitivity and 
adiponectin at baseline in adults with T2D (Al-Sofiani et al., 2015) suggesting 
adiponectin may play a role in metabolic pathways that control glycaemia. 
Adiponectin favours the uptake of glucose into skeletal muscle and thus is 
regarded as a predictor for reducing hyperglycaemia (Punthakee et al., 2006). 
This is assumed to be through insulin-mediated pathways, suggesting 
changes in the blood insulin profile. Changes in free-fatty acid concentrations 
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and metabolism that are induced by exercise can also determine 
improvements in glycaemia, which may be linked to changes in circulating 
adiponectin (Johannsen et al., 2013).  
 
2.6 Summary 
Independently, both exercise and vitamin D3 supplementation indirectly and 
directly induce beneficial responses and adaptations on insulin sensitivity and 
glucose regulation.  
Vitamin D supplementation with the aim to increase concentrations, ideally to 
a sufficient concentration (>30 ng·ml-1), has been reported to induce a 
reduction in fasting glucose (Salehpour et al., 2013; Talaei et al., 2013), and 
improve insulin sensitivity (von Hurst et al., 2010; Nazarian et al., 2011; 
Belenchia et al., 2013; Talaei et al., 2013). Independent of vitamin D 
supplementation studies, the benefit of HIIT have been demonstrated through 
reported reductions in fasting insulin (Trapp et al., 2008; Whyte et al., 2010; 
Iellamo et al., 2013; Racil et al., 2013), reductions in fasting glucose (Mitranun 
et al., 2014; Shaban et al., 2014), and improvements in glucose tolerance 
shown through reductions in glucose and insulin AUC following an OGTT 
(Babraj et al., 2009; Little et al., 2011; Adamson et al., 2014).  
Both HIIT and vitamin D3 supplementation can independently improve glucose 
regulation and the body’s response to insulin, and influence concentrations of 
leptin (Trapp et al., 2008; Belenchia et al., 2013; Ghavamzadeh et al., 2014) 
and adiponectin (Leggate et al., 2012; Breslavsky et al., 2013; Racil et al., 
2013). However, there is very little research investigating a combined effect of 
vitamin D supplementation and exercise training on these markers. Recent 
studies have suggested that the effect on glucose control is independently 
regulated by vitamin D status/supplementation and exercise training (Barker 
et al., 2013; Kobza et al., 2013), although HIIT has not been used as the 
exercise model in parallel to supplementation. 
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2.7 Aims and hypothesis 
This project will aim to investigate whether there is a combined effect of HIIT 
and vitamin D supplementation on insulin sensitivity, and determine the 
magnitude of effect HIIT has on markers of physical capacity and metabolism. 
It is hypothesised that the additive effect of vitamin D will augment the 
improvement in insulin sensitivity observed through 6 weeks of HIIT. 
Furthermore, HIIT alone will induce cardiovascular and metabolic adaptations 
that benefit the insulin and glycaemic profile. 
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3.0 Materials and methods 
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3.1 Overview of study 
The study is a placebo-controlled randomised trial investigating the combined 
effect of HIIT and 25(OH)D3 supplementation on insulin sensitivity: assessed 
via a 75 g OGTT. Overweight/obese and inactive adults were recruited to 
complete 6 weeks of HIIT and receive either a 25(OH)D3 supplement or a 
placebo, 1 per day (42 in total), for the duration of training. In order to introduce 
periodisation into the training programme, the workload of the high intensity 
intervals was increased by 10 % of peak oxygen uptake (V̇O2peak) every 2 
weeks/6 sessions. This ensured participants were working in a specific HR 
zone throughout the entire intervention. Pre- and post-training measurements 
were taken to determine the metabolic adaptations following 6 weeks of HIIT 
with or without 25(OH)D3 supplementation, with physiological data taken every 
2 weeks to monitor progress.  
 
3.2 Participants and ethical approval 
Participants (n=12, 9 males and 3 females) were recruited from the Edinburgh 
area via: posters, social media (Facebook, Twitter and Gumtree), letters sent 
to Edinburgh based companies and organisations, and presentations to 
university students. Participants’ baseline characteristics are provided in Table 
1. 
The inclusion criteria requested Caucasian overweight and obese males and 
females between the ages of 18 to 45 y with a BMI of 27-35 kg·m-2 who 
undertake 2 or less bouts of light to moderate intensity exercise per week. Only 
Caucasian individuals were included as skin colour/pigmentation is associated 
with T2D and hyperglycemia (Parra et al., 2004). The exclusion criteria 
excluded persons who have diagnosed diabetes, current smokers (or a 
smoker who has quit less than 15 months ago), use of tanning beds or undergo 
UV light therapy, take vitamin D tablets or any multivitamins containing vitamin 
D, take part in more than 2 bouts of light to moderate intensity exercise per 
week. Females were included only if they were on hormonal control as the 
menstrual cycle alters glucose metabolism (Widom et al., 1992). 
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All participants were asked to complete a health and physiology screening 
questionnaire (Appendix 1 A) and provide written and verbal consent 
(Appendix 1 B) to verify eligibility for the study. 
Ethical approval for the study was granted by the Faculty of Health, Life, and 
Social Sciences Research Integrity Approvals Group at Edinburgh Napier 
University. 
 
Table 1: Baseline participant characteristics 
 All Placebo Vitamin D 
N (males:females) 12 (9:3) 6 (5:1) 6 (4:2) 
Age, y 32 ± 8 32 ± 9 33 ± 7 
Height, m 1.73 ± 0.10 1.77 ± 0.09 1.69 ± 0.10 
Body Mass, kg 96.0 ± 15.6 90.6 ± 11.9 101.5 ± 18.0 * 
BMI, kg·m-2 31.9 ± 2.8 29.7 ± 2.0 34.1 ± 1.5 
Waist circumference, cm 100 ± 10 96 ± 9 103 ± 11 
Hip circumference, cm 111 ± 6 107 ± 4 116 ± 5 
Waist-to-hip ratio 0.90 ± 0.08 0.90 ± 0.09 0.89 ± 0.08 
Resting HR, bmp 73 ± 10 71 ± 10 75 ± 10 
Systolic blood pressure, mmHg 132 ± 10 130 ± 13 133 ± 6 
Diastolic blood pressure, mmHg 81 ± 8 79 ± 1 84 ± 6 
Fasting glucose, mmol·L-1 4.8 ± 0.5 4.7 ± 0.5 4.9 ± 0.6 
Fasting insulin, mU·L-1 7.0 ± 3.8 8.1 ± 3.5 8.4 ± 5.3 
*Significantly different compared with placebo (P<0.05). All data is presented as mean ± 
standard deviation (SD). 
 
3.3 Control measures 
Participants were asked to abstain from consuming caffeine and alcohol and 
engaging in strenuous exercise in the 24 h prior to the V̇O2peak test and the 
OGTT. Participants were asked to maintain their normal diet and habitual 
activity for the duration of the intervention.  
Environmental conditions were not controlled but were recorded at the 
beginning of each visit: temperature, barometric pressure, and humidity.  
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3.4 Visit 1 
 
3.4.1 Anthropometric measurements and blood pressure 
On arrival to the Sport and Exercise Science laboratory participant’s height 
and body mass were measured via a Stadiometer (Harpenden Portable, 
Holtain Limited, UK) and scales (Seca, 808, Germany), respectively. Waist and 
hip circumference were also measured using a standard measuring tape. 
Waist circumference was measured half way between the iliac crest and the 
lowest rib. Hip circumference was measured at the widest part of the hips 
(WHO, 2008). These measurements were then used to calculate the waist-to-
hip ratio. 
Body mass was measured at the beginning of every visit to the laboratory. 
Waist and hip circumferences were measured at the start of each 2 week stage 
(sessions 1, 7 and 13) and in the post-intervention session (visit 21). 
Arterial blood pressure was measured on the participant’s non-dominant arm 
using a digital automatic blood pressure monitor (Omron, R5-1, Japan). 
Participants remained in a seated position for 10 min prior to the first 
measurement. Blood pressure was taken 3 times and an average of the 
second and third readings was reported. If blood pressure was >150/100 
mmHg, participants were excluded from the study and informed to contact their 
GP. 
 
3.4.2 Peak oxygen uptake test 
Participants V̇O2peak was determined using a continuous incremental exercise 
test on an electromagnetically-braked cycle ergometer (Velotron Pro, Racer 
Mate, USA), performed to volitional exhaustion (Yoon et al., 2007; Poole et al., 
2008). An on-line breath-by-breath gas analysis system (Cortex, MetaLyzer 
3B, Germany) was used to measure expired air continuously throughout the 
test. Calibration of the flow sensor and the gas analysis system was performed 
30 min prior to each use. Heart rate was also continuously monitored 
throughout the test by a HR monitor (Polar, RS400, Finland) and the HR 
sensor linked to the gas analysis system. After a 5 min warm up at 50 W, the 
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intensity increased by 25 W every 2 min until volitional exhaustion was 
achieved. Participants were instructed to maintain a pedalling rate of 60 
revolutions per min (rpm). Participants were verbally encouraged to perform to 
volitional exhaustion and the test was terminated when the pedalling rate fell 
below 55 rpm. A 5 min cool down at 50 W was then immediately completed. 
Peak oxygen uptake was identified as the highest V̇O2 over a 30 s period 
during the test.  
 
3.4.3 Familiarisation trial 
In the same session, following 30 min rest in a seated position after completion 
of the V̇O2peak test, a familiarisation trial for the HIIT protocol was performed. 
This involved a shortened version of the HIIT protocol consisting of 5 x 1 min 
intervals at 100 % V̇O2peak interspersed with 1 min at 30 W. Breath-by-breath 
data and HR data was gathered for the duration of the familiarisation session. 
This session was to familiarise the participant with the structure of the HIIT 
protocol and to ensure that HRpeak was within the desired HR zone of 85-95 % 
HRpeak (determined in the V̇O2peak test) prior to the training sessions.  
 
3.5 Visit 2 
 
3.5.1 Oral glucose tolerance test 
This test occurred 4-5 days after the V̇O2peak test session to prevent any 
residual effects influencing the metabolic/biological markers measured during 
the glucose test. Participants attended the laboratory between 7.30-8.30am 
following an overnight fast (≥10 h) to complete a 75 g OGTT. Resting blood 
samples (3 x 4 ml) were taken via an indwelling cannula, then participants 
consumed 82.5 g of dextrose monohydrate dissolved in 290 ml of water and 
10 ml of lemon juice over a 5 min period. Further blood samples (2 x 4ml) were 
subsequently taken every 30 min for 2 h. Participants were required to remain 
in a seated position for the 2 h period. 
 
 
35 
 
3.6 Visits 3-20 
 
3.6.1 High intensity intermittent training 
Training was initiated within 1-3 days following the OGTT, depending on 
participants’ availability, and consisted of 6 weeks training and 3 
sessions/week of HIIT: separated by 1-2 days to allow muscle recovery and 
rest. The HIIT protocol is based on that utilised in recent studies (Little et al., 
2010; Little et al., 2011; Little et al., 2014; Mancilla et al., 2014). Participants 
completed a warm up and cool down consisting of 5 min at a low power output 
of 50 W. The protocol consisted of 10 x 1 min intervals at a power output 
corresponding to: 100 % V̇O2peak (determined in visit 1) in sessions 1-6; 110 % 
of V̇O2peak in sessions 7-12; 120 % of V̇O2peak in sessions 13-18. The 
percentage of V̇O2peak (100, 110 and 120 %) and corresponding 
workload/power output for the high intensity intervals was determined using 
the equation of the trend-line from a plotted graph of V̇O2 (x axis) against power 
output (y axis), and adjusted accordingly following the familiarisation trial. The 
intervals were interspersed with 1 min active recovery periods set at 30 W. 
Figure 4 illustrates a schematic timeline of a single session of the HIIT. Heart 
rate was also continuously monitored throughout the test by a HR monitor 
(Polar, RS400, Finland) 
 
 
Figure 4: Schematic diagram of a HIIT session 
 
3.6.2 25(OH)D3 Supplementation 
Participants were randomised (1:1) to receive a 6 week course of 25(OH)D3 
capsules or placebo tablets- 1 per day. Randomisation of the supplements and 
placebo was blind to both participant and researcher and controlled by the 
laboratory technicians. Supplements and placebo were distributed in brown 
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envelopes to participants, which included instructions for consumption. Each 
of the 25(OH)D3 capsules (Solgar, New Jersey, USA) contained a dose of 
4000 IU/day (100 mg), which corresponds to the upper intake level set by IOM 
(2010). The placebo was a commercially available lactose tablet (Placebo-
World, Powys, UK), with one consumed daily. Participants were asked to 
consume one supplement or placebo per day at a similar time in the morning, 
and were reminded at each training session to continue taking the tablets daily. 
Adherence to supplement and placebo consumption was self-reported by 
participants and is reported as 100 % compliance. 
 
3.7 Visit 21 
 
3.7.1 Post-training OGTT and V̇O2peak test 
The OGTT and V̇O2peak were repeated approximately 72 h post-training. The 
same procedures were followed for both trials and completed at the same time 
of day. Upon completion of the OGTT, participants rested for 30 min in a 
seated position before performing the V̇O2peak test.  
 
3.8 Blood sampling 
All venous blood samples (44 ml in total) were taken from the antecubital vein 
in the forearm via cannulation using a 20 G BD Venflon Pro Safety I.V. cannula 
(Sweden). Connecta tubing was used to prevent movement of the positioning 
of the needle. The cannula was kept patent via syringe flushing between 
samples with 5 ml of 0.9 (w/v) saline solution. A Terumo syringe was used to 
extract the first 2.5 ml of blood and was discarded prior to sample collection. 
Blood samples were collected in 4 ml capacity BD vacutainers: grey-topped 
vacutainers containing sodium fluoride/potassium oxalate for glucose 
concentration analysis and lavender-topped vacutainers containing K3 
ethylenediaminetetraacetic acid (EDTA) (approximately 1.0 mg) for insulin, 
vitamin D, and adiponectin concentration analysis. The blood samples were 
inverted 8 times then placed on ice. 
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For plasma analysis, the whole blood was centrifuged (Satorius Universal, 
320R, Germany) at 1500 rpm for 15 min at 4 °C within 30 min of collection, 
and the resulting plasma aliquoted into eppendorfs and stored at -80 °C for 
subsequent analysis. 
Participants were in a seated position on a laboratory bed for all blood 
sampling. 
 
3.9 Blood sample analysis 
All assays and analysis methods were performed in duplicate. All plasma 
samples were thawed prior to analysis. 
 
3.9.1 Enzyme-linked immunosorbent assays (ELISA) 
Plasma insulin concentrations were determined using a commercially available 
ELISA kit, with human low and high controls (Mercodia, Uppsala, Sweden). 
Fasting plasma 25(OH)D3 (IDS PLC, Tyne and Wear, UK), adiponectin, and 
leptin concentrations were analysed via commercially available ELISA kits 
before and after the 6 week intervention (R&D Systems, Minneapolis, USA).  
 
3.9.2 Biochemical analysis 
Plasma glucose, total cholesterol, triglyceride, and HDL cholesterol 
concentrations were analysed using a bench top clinical chemistry analyser 
(Randox, RX Monza, UK). Low density lipid (LDL) cholesterol concentration 
was calculated using the following equation:  
LDL cholesterol = 𝑇𝑜𝑡𝑎𝑙 𝑐ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 − 
𝑇𝑟𝑖𝑔𝑙𝑦𝑐𝑒𝑟𝑖𝑑𝑒𝑠
2.2
− 𝐻𝐷𝐿 𝑐ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 
 
3.9.3 Haematological analysis 
Whole blood was analysed for full blood cell count in vacutainers containing 
K3 EDTA using a haematology analyser (Sysmex, XS 1000i, USA). 
Haemoglobin (Hb) concentration, haematocrit (Hct) content, red blood cell 
count, and white blood cell count and components were measured.  
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3.9.4 Coefficient of variation (CV) 
All CV values for all assays and analysis methods are displayed in Table 2. 
 
Table 2 CV values for all assays and analysis methods 
 Analysis method Intra-CV (%) Inter-CV (%) 
   Control 1 Control 2 
Insulin ELISA 4.76 0.22 4.23 
Vitamin D ELISA 3.43   
Adiponectin ELISA 3.72   
Leptin ELISA 5.15   
Glucose Clinical chemistry analyser 0.17   
Cholesterol Clinical chemistry analyser 0.1   
HDL cholesterol Clinical chemistry analyser 0.72   
Triglyceride Clinical chemistry analyser 0.24   
Haematology Clinical chemistry analyser 3.64   
 
3.9.5 Plasma volume changes (PVC) 
Changes in plasma volume from pre-to post-training were calculated using a 
previously outlined method (Dill and Costill, 1974) to determine if PVC would 
affect the outcomes. 
 
3.9.6 Insulin Sensitivity Index (ISI) 
Insulin sensitivity was assessed as the insulin sensitivity index (ISI) calculated 
using the OGTT results and formula proposed by Matsuda and DeFronzo 
(1999).  
ISI = 
10000
√(𝐹𝑃𝐺∗𝐹𝑃𝐼)∗(𝐺∗𝐼)
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Homeostatic model assessment-insulin resistance (HOMA-IR) was also 
calculated.  
HOMA-IR = 
𝐹𝑃𝐺∗𝐹𝑃𝐼
22.5
 
Where: 
FPG is the fasting plasma glucose 
FPI is the fasting plasma insulin 
G is the mean plasma glucose during the OGTT 
I is the mean plasma insulin during the OGTT 
 
3.10 Statistical analysis 
Data was checked for skewness. All data except the insulin data from the 
OGTT was normally distributed and parametric tests were used. The insulin 
data was log transformed prior to statistical analysis. Differences in participant 
characteristics, V̇O2peak test outcomes, fasted plasma glucose, insulin, glucose 
AUC, insulin AUC, 25(OH)D3, adiponectin, leptin, and lipids, pre- and post-
intervention, were analysed using a two-way repeated measures analysis of 
variance (ANOVA) for overall effect. A repeated measures ANOVA was also 
used to analyse the insulin and glucose response to an OGTT. If a main effect 
of time and an interaction effect between groups was observed, Bonferroni 
post-hoc analysis were performed using paired samples t-tests to compare 
pre-training to post-training. All statistical analyses were performed using 
SPSS software (20.0) and data presented as means ± SD. Significance was 
accepted at P<0.05.   
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4.0 Results 
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4.1 25-hydroxyvitamin D3  
There was a main effect of time for 25(OH)D3 (F=7.847, P=0.019, Figure 5 A), 
however no interaction effect between groups (F=0.344, P=0.570). All 
participants were deficient at baseline (<20 ng·ml-1) as shown by the individual 
responses in Figure 5 B. Following 6 weeks of supplementation, the vitamin D 
group resulted in 50 % of participants no longer deficient (>20 ng·ml-1) and 
16.6 % reporting sufficiency (>30 ng·ml-1), and participants as a whole resulted 
in 41.6 % no longer deficient and 8.4 % sufficient post-training. 
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Figure 5: (A) Pre- and post-training 25(OH)D3 concentration for all participants (n=12), the 
placebo group (n=6), and the vitamin D group (n=6); (B) individual changes in 25(OH)D3 pre- 
to post-training. *Denotes a main effect of time (P<0.05). 
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4.2 Exercise outcomes 
Exercise intensity across all intervals during HIIT averaged 89 ± 5 % of HRpeak 
and 97.2 ± 8.4 % of V̇O2peak. Table 3 shows the mean power output that 
participants cycled for all 10 intervals during sessions 1, 7 and 13 when the 
intensity was increased (F=359.097, P=0.000) by the corresponding workload 
to 10 % of V̇O2peak to allow periodisation of training. Table 3 also presents HR 
and V̇O2 averaged across all 10 intervals in these sessions. There was no 
change in HR between the three sessions (F=0.053, P=0.949) but V̇O2 
observed a time effect (F=29.651, P=0.000) with an increase every 2 weeks 
(P≤0.001). 
  
Table 3: Power output, HR and V̇O2 averaged across all 10 intervals in HIIT session 1, 7, and 
13. 
 Session 1 Session 7 Session 13 P value 
Power output (W) 227 ± 42 250 ± 46 273 ± 50 <0.001 
HR (bpm) 166 ± 13 166 ± 14 166 ± 15 0.949 
V̇O2 (ml·kg-1·min-1) 27.2 ± 2.7 28.7 ± 2.3 30.3 ± 3.2 <0.001 
All data is presented as mean ± SD. 
 
Figure 6 illustrates the percentage of baseline peak HR (A) and peak V̇O2 (B) 
that participants were cycling at for each of the intervals in session 1, 7, and 
13. In each of these sessions V̇O2peak averaged 91.7 ± 7.7 %, 97.0 ± 7.8 %, 
and 101.5 ± 8.4 % of baseline V̇̇O2peak. Participants performed the HIIT training 
in the same HR zone for each session as shown in Figure 6 A, with an 
observed increase in V̇O2peak. As a result of every 2 weeks of training, V̇O2 was 
increased (F=29.651, P<0.001). 
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Figure 6: The percentage of baseline (A) peak HR and (B) peak V̇O2 that participants were 
cycling at during the individual intervals in the first, seventh and thirteenth HIIT sessions 
(n=12). 
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As displayed in Figure 7, the absolute and relative V̇O2peak at baseline for all 
participants was 2.86 ± 0.56 L·min-1 and 29.7 ± 2.7 ml·min-1·kg-1, respectively, 
and occurred at a mean power output of 227 ± 42 W. The absolute and relative 
V̇O2peak at baseline for the placebo group was 3.05 ± 0.65 L·min-1 and 28.8 ± 
3.1 ml·min-1·kg-1, respectively, and occurred at a mean power output of 237 ± 
51 W; and the vitamin D group was 2.67 ± 0.41 L·min-1 and 30.7 ± 2.2 ml·min-
1·kg-1, respectively, and occurred at a mean power output of 217 ± 31 W. 
As a result of the 6 weeks of HIIT training there was a main effect of time in 
absolute V̇O2peak (F=14.797, P=0.004, Figure 7 A). Relative V̇O2peak observed 
a main effect of time (F=16.631, P=0.003, Figure 7 B). There was no 
interaction effect between groups for absolute or relative V̇O2peak at 6 weeks. 
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Figure 7: Absolute V̇O2peak (A) and relative V̇O2peak (B) pre- and post-training for all participants 
(n=12), the placebo group (n=6), and the vitamin D group (n=6). *Denotes a main effect of 
time (P<0.05). 
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There was a main effect of time on absolute peak power output (F=23.233, 
P=0.001, Figure 8 A). This was consistent in peak power relative to body mass, 
with a main effect of time (F=21.584, P=0.001, Figure 8 B). There was no 
interaction effect between groups for absolute or relative peak power output at 
6 weeks. 
 
 
 
 
 
Figure 8: Absolute Wpeak (A) and relative Wpeak (B) pre- and post-training for all participants 
(n=12), the placebo group (n=6), and vitamin D group (n=6). *Denotes a main effect of time 
(P<0.05).  
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4.3 Participant characteristics 
 
4.3.1 Physical and metabolic characteristics 
Physical and metabolic characteristics of all participants are shown in Table 4. 
All participants completed all supervised sessions and intervals within the 
sessions with no complications or interruptions: 100 % adherence and 
compliance. 
No significant differences existed between the placebo group and vitamin D 
group at baseline except for body mass (P=0.036) and hip circumference 
(P=0.020).  
Hip circumference (F=4.216, P=0.067) and waist circumference (F=0.473, 
P=0.507) observed no main effect of time. Additionally, body mass did not 
differ from pre- to post-training (F=0.781, P=0.398). There was a main effect 
of time on systolic blood pressure (F=8.448, P=0.016). Diastolic blood 
pressure did not observe an effect of time in any group (F=1.337, P=0.274). 
Resting HR also did not differ after 6 weeks of HIIT (F=3.301, P=0.099). There 
were no interaction effects between groups for any of the physical and 
metabolic characteristics. 
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Table 4: Pre- and post-training values for all participants, the placebo group, and the vitamin D group 
All data is presented as mean ± SD. 
 
  
 All Placebo Vitamin D 
Main Effect 
of Time 
Interaction Effect 
Between Groups 
 
 
Pre-training Post-training Pre-training Post-training Pre-training Post-training P Value P Value 
N (males:females) 12 (9:3) 12 (9:3) 6 (5:1) 6 (5:1) 6 (4:2) 6 (4:2)   
Body Mass, kg 96.0 ± 15.6 95.4 ± 14.6 101.5 ± 18.0 100.0 ± 16.5 90.6 ± 11.9 90.8 ± 12.0 0.398 0.664 
BMI, kg·m-2 31.9 ± 2.8 31.7 ± 2.6 34.1 ± 1.5 33.6 ± 0.7 29.7 ± 2.0 29.7 ± 2.2 0.445 0.643 
Waist circumference, cm 100 ± 10 99 ± 10 103 ± 11 103 ± 8 96 ± 9 95 ± 10 0.507 0.148 
Hip circumference, cm 111 ± 6 110 ± 8 116 ± 4 116 ± 6 107 ± 4 105 ± 5 0.067 0.054 
Waist-to-hip ratio 0.90 ± 0.08 0.90 ± 0.07 0.89 ± 0.08 0.89 ±0.09 0.90 ± 0.09 0.91 ±0.06 0.935 0.548 
Waist-to-height ratio 0.57 ± 0.04 0.57 ± 0.05 0.58 ± 0.03 0.59 ± 0.02 0.57 ± 0.06 0.55 ± 0.05 0.551 0.131 
Resting HR rate, bmp 73 ± 10 68 ± 9 75 ± 10 72 ± 8 71 ± 10 65 ± 8 0.099 0.951 
Systolic blood pressure, mmHg 132 ± 10 124 ± 13 133 ± 6 125 ± 16 130 ± 13 123 ± 11 0.016 0.345 
Diastolic blood pressure, mmHg 81 ± 8 79 ± 8 84 ± 6 78 ± 12 79 ± 10 79 ± 4 0.274 0.911 
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4.3.2 Haematological values 
All haematological values are displayed in Table 5. There were no main 
effects of time or interaction effects between groups for any of the 
haematological markers. 
 
4.3.3 PVC 
There were no significant differences in plasma volume from pre- to post-
training (F=0.310, P=0.585), therefore the unadjusted data is reported and no 
changes were made to any outcomes.  
 
  
51 
 
Table 5: Haematological values for all participants, the placebo group, and the vitamin D group pre- and post-training. 
 All Placebo Vitamin D 
Main Effect 
of Time 
Interaction Effect 
Between Groups 
 
 
Pre-training Post-training Pre-training Post-training Pre-training Post-training P Value P Value 
WBC (103·µL) 6.2 ± 1.6 5.8 ± 1.4 5.5 ± 1.2 5.7 ± 1.4 6.8 ± 1.8 5.8 ± 1.5 0.346 0.159 
RBC (103·µL) 4.9 ± 0.3 5.0 ± 0.6 5.0 ± 0.3 5.1 ± 0.8 4.9 ± 0.3 4.8 ± 0.5 0.596 0.249 
Hb (g·dL) 14.7 ± 1.0 14.8 ± 1.8 14.9 ± 0.8 15.1 ± 1.9 14.6 ± 1.2 14.4 ± 1.7 0.633 0.225 
Hct (%) 43.2 ± 2.5 43.7 ± 5.1 43.7 ± 2.5 44.9 ± 6.1 42.7 ± 2.7 42.6 ± 4.1 0.485 0.244 
PLT (103·µL) 265 ± 73 267 ± 118 252 ± 64 237 ± 98 279 ± 84 297 ± 138 0.646 0.798 
Neutrophils (109·L) 3.6 ± 1.5 3.2 ± 1.0 3.1 ± 0.9 3.3 ± 0.9 4.1 ± 1.8 3.1 ± 1.0 0.315 0.113 
Lymphocytes (109·L) 1.83 ± 0.41 1.86 ± 0.45 1.69 ± 0.39 1.73 ± 0.55 1.97 ± 0.41 1.99 ± 0.31 0.928 0.939 
Monocytes (109·L) 0.48 ± 0.09 0.50 ± 0.18 0.46 ± 0.09 0.47 ± 0.19 0.50 ± 0.09 0.52 ± 0.20 0.897 0.982 
Eosinophils (109·L) 0.19 ± 0.08 0.16 ± 0.07 0.22 ± 0.11 0.14 ± 0.07 0.16 ± 0.04 0.17 ± 0.08 0.170 0.192 
Basophiles (109·L) 0.02 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.498 0.692 
WBC, white blood cell count; RBC, red blood cell count; Hb, haemoglobin; Hct, haematocrit, PLT, platelets. All data is presented as mean ± SD. 
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4.4 OGTT outcomes and insulin sensitivity 
There was a main effect of time in the insulin response to a 75 g OGTT in all 
participants (F=5.129, P=0.009, Figure 9 A), with further analysis showing 
significant differences between pre- and post-training at 30 min (P=0.025) and 
120 min post-prandial (P=0.004). No main effect of time was observed for the 
glucose response to an OGTT (F=1.026, P=0.511, Figure 9 B).  
 
 
 
 
 
 
Figure 9: Plasma glucose (A) and insulin (B) responses to a 75 g OGTT pre- and post-training 
for all participants (n=12). 
0
2
4
6
8
10
12
0 30 60 90 120
G
lu
c
o
s
e
 (
m
m
o
l·
l-
1
)
Time (min)
0
20
40
60
80
100
120
140
160
180
0 30 60 90 120
In
s
u
li
n
 (
m
U
·l
-1
)
Time (min)
A 
B 
Pre-training 
Post-training 
 
53 
 
The glucose and insulin responses to the 2 h OGTT pre- and post-training for 
both groups are shown in Figure 10 A and B. There was no interaction effect 
between the two groups for insulin (F=0.949, P=0.353) or glucose (F=1.091, 
P=0.321) responses. 
 
 
 
Figure 10: Plasma glucose (A) and insulin (B) responses to a 75 g OGTT pre- and post-training 
for the placebo group (n=6) and the vitamin D group (n=6). 
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The glycaemic indices including AUC and insulin sensitivity are shown in Table 
6. There were no significant changes in fasting plasma insulin (F=0.100, 
P=0.758) and glucose (F=1.487, P=0.251) concentration after 6 weeks of HIIT. 
No main effect of time was observed for glucose AUC (F=2.997, P=0.114). 
Insulin sensitivity index (ISI) (Matsuda and DeFronzo, 1999) and HOMA-IR 
(homeostatic model assessment-insulin resistance) remained unchanged pre- 
to post-training (F=2.131, P=0.175; F=0.237, P=0.637). 
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Table 6: Pre- and post-training glycaemic indices 
 All (n=12) Placebo (n=6) Vitamin D (n=6) 
Main Effect 
of Time 
Interaction Effect 
Between Groups 
 Pre-training Post-training Pre-training Post-training Pre-training Post-training P Value P Value 
Fasting glucose, mmol·L-1 4.8 ± 0.5 4.9 ± 0.7 5.0 ± 0.6 4.8 ± 0.6 4.7 ± 0.5 4.8 ± 0.8 0.251 0.118 
Fasting insulin, mU·L-1 6.7 ± 3.3 7.0 ± 4.3 8.1 ± 3.5 8.4 ± 5.3 5.3 ± 2.6 5.5 ± 3.0 0.758 0.995 
Glucose AUC, mmol·h-1·L-1 796 ± 98 742 ± 97 846 ± 114 763 ± 114 747 ± 48 722 ± 83 0.114 0.379 
Insulin AUC, mU·h-1·L-1 7734 ± 5327 6366 ± 4094 8638 ± 5087 7204 ± 5079 6836 ± 5882 5527 ± 3064 0.123 0.940 
Insulin sensitivity index† 10.12 ± 8.75 15.71 ± 19.62 7.48 ± 8.99 18.15 ± 26.84 12.77 ± 8.42 13.28 ±10.61 0.175 0.214 
HOMA-IR 1.47 ± 0.78 1.57 ± 1.06 1.80 ± 0.82 1.89 ± 1.26 1.14 ± 0.64 1.24 ± 0.8 0.637 0.965 
HOMA-IR, homeostatic model assessment-insulin resistance. † Insulin sensitivity index calculation derived by Matsuda & DeFronzo (1999). All data is presented 
as mean ± SD. 
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4.5 Adiponectin and leptin 
A main effect of time was observed for plasma adiponectin after the 6 week 
training period (F=13.604, P=0.004, Figure 11 A), however there was no 
interaction effect between groups (F=3.353, P=0.097, Figure 11 A). The 
individual responses for adiponectin are shown in Figure 11 B.  
 
 
 
 
Figure 11: Group and individual changes for adiponectin: (A) baseline and post-intervention 
adiponectin for all participants (n=12), the placebo group (n=6), and the vitamin D group (n=6); 
(B) adiponectin individual changes (n=12). *Denotes a main effect of time (P<0.05). 
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There was no main effect for pre- versus post-training in plasma leptin 
(F=1.487, P=0.251; Figure 12 A), and no interaction effect between groups 
(F=2.932, P=0.148, Figure 12 A). The individual responses for leptin are also 
shown in Figure 12 B. 
 
 
 
 
 
Figure 12: Group and individual changes for leptin: (A) baseline and post-intervention leptin 
for all participants (n=12), the placebo group (n=6), and the vitamin D group (n=6); (B) leptin 
individual changes (n=12). 
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4.6 Lipids 
Table 7 shows pre- and post-intervention indices for lipids for all participants 
and both groups. There was a main effect of time in triglycerides (F=8.798, 
P=0.014), however no interaction effect between groups was observed 
(F=1.426, P=0.260). There was no effect of time on total cholesterol (F=1.237, 
P=0.292), HDL cholesterol (F=1.742, P=0.216), or LDL cholesterol (F=2.542, 
P=0.142).  
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Table 7: Blood lipid biomarkers pre- and post-training for all groups 
 All (n=12) Placebo (n=6) Vitamin D (n=6) 
Main Effect 
of Time 
Interaction Effect 
Between Groups 
 
 
Pre-training Post-training Pre-training Post-training Pre-training Post-training P Value P Value 
Cholesterol, mmol·L-1 4.74 ± 0.89 4.90 ± 0.71 4.91 ± 0.99 5.17 ± 0.81 4.56 ± 0.83 4.64 ± 0.54 0.292 0.593 
Triglycerides, mmol·L-1 1.61 ± 0.72 1.45 ± 0.72 1.62 ± 0.75 1.39 ± 0.73 1.61 ± 0.77 1.51 ± 0.76 0.014 0.260 
HDL-chol, mmol·L-1 1.17 ± 0.26 1.14 ± 0.24 1.21 ± 0.31 1.19 ± 0.31 1.12 ± 0.21 1.10 ± 0.17 0.260 0.860 
LDL-chol, mmol·L-1 2.83 ± 0.82 3.10 ± 0.56 2.97 ± 0.88 3.35 ± 0.52 2.70 ± 0.82 2.86 ± 0.52 0.142 0.524 
HDL-chol, high density lipid cholesterol; LDL-chol, low density lipid cholesterol. All data is presented as mean ± SD. 
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5.0 Discussion 
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5.1 Key findings 
 
 All participants, who permanently reside in Scotland, were 25(OH)D3 
deficient at baseline and supplementation with 4000 IU/day increased 
concentrations but not to sufficient concentration; 
 Six weeks of HIIT in an overweight and obese cohort induced an increase 
in peak V̇O2, with periodisation of training ensuring all sessions were 
performed in the same HR zone; 
 Six weeks of HIIT and 25(OH)D3 supplementation did not induce a change 
in fasting glucose or insulin or the insulin sensitivity index in adults with 
normal glucose tolerance; 
 Adiponectin was attenuated after 6 weeks of HIIT in the placebo group and 
in all participants, however was not detrimentally reduced in the vitamin D 
group;  
 Leptin did not respond to 6 weeks of training and/or 25(OH)D3 
supplementation;  
 Plasma triglycerides were reduced in all participants after 6 weeks of HIIT. 
 
5.2 Vitamin D status and effect of supplementation 
At baseline all of the participants involved in the current study, who reside in 
Scotland, were 25(OH)D3 deficient (<20 ng·ml-1). Major differences in vitamin 
D status have been found between different regions of the world, primarily 
attributed to a latitude and ‘sun’ effect since 80 % of vitamin D intake is through 
sunlight exposure of a specific wavelength: 290-315 nm (Chapuy et al., 1997; 
Holick, 2002). Exposure to this strength of UV rays stimulates the conversion 
of vitamin D to the active form: 25(OH)D3 (Kumar, 1984). Scotland in particular 
has been identified as a nation that is likely to suffer from vitamin D deficiency 
(Hypponen and Power, 2007). This geographical influence is accompanied 
with a seasonal effect (Bolland et al., 2007), whereby winter months generally 
depict a higher prevalence of 25(OH)D3 insufficiency/deficiency (Belenchia et 
al., 2013). Diet fails to provide an adequate amount of vitamin D to maintain a 
sufficient status (>30 ng·ml-1), presenting the need for supplementation 
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(Chapuy et al., 1997). Data collection for the current study was obtained 
between the months of September to April, therefore the influence of the sun 
in Scotland is unlikely to facilitate vitamin D synthesis and influence vitamin D 
status of the participants (Rhodes et al., 2010). 
Studies investigating the effects of 25(OH)D3 supplementation have utilised a 
range of daily or weekly doses. The relatively high 4000 IU/day (100 µg/day) 
dose used in the current study was selected based on the susceptibility of 
overweight/obese adults to be vitamin D deficient (Bolland et al., 2007). 
Additionally, the dose does not exceed the upper tolerable limit determined by 
the Institute of Medicine (IOM) in 2010. After the 6 week intervention, there 
was a 33.5 % increase in 25(OH)D3 concentration in those consuming 4000 
IU/day, which is slightly less of a rise than other studies using the same dose 
but longer interventions: 12 weeks – 6 months (von Hurst et al., 2010; Harris 
et al., 2012; Belenchia et al., 2013). Studies involving relatively short 
supplementation periods of 4 and 8 weeks have supplemented much higher 
doses of 10,000 IU/day and 50,000 IU/week, respectively, and reported 
greater increases in 25(OH)D3 concentration and an improvement in insulin 
sensitivity (Nazarian et al., 2011; Talaei et al., 2013), however baseline 
concentrations were elevated in comparison to the present study’s findings: 20 
± 7 ng·ml-1 (n=8) and 43 ng·ml-1 (n=100) compared to 13 ± 3 ng·ml-1 (n=12), 
respectively. 
There was no observed effect on insulin sensitivity in the current study. An 
increase in 25(OH)D3 concentration alone may not be sufficient to induce an 
increase in insulin sensitivity or improve glycemic control. Improvements in 
insulin resistance and fasting plasma insulin have been found when 
concentrations exceed 30 ng·ml-1 (Belenchia et al., 2013), which is the defined 
concentration of a ‘sufficient’ status. In the current study, despite a rise in 
25(OH)D3 concentrations to 20 ± 9 ng·ml-1 in all participants (n=12) and 22 
ng·ml-1 in the vitamin D group alone (n=6) after 6 weeks of supplementation, 
the rise alone may not have been sufficient to improve insulin sensitivity: 
concentrations must exceed 30 ng·ml-1. However, studies utilising lower doses 
over longer durations reported increases in 25(OH)D3 concentration to a 
sufficient status (>30 ng·ml-1) but were not accompanied with an improvement 
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in glucose tolerance (Mitri et al., 2011; Breslavsky et al., 2013; Ghavamzadeh 
et al., 2014; Nader et al., 2014; Ryu et al., 2014). Furthermore, the 
responder/non-responder theory can account for varying individual responses 
to supplementation (Saksa et al., 2015). The ingested supplement must be 
metabolised to the active and transportable form of vitamin D (25(OH)D3), and 
subsequently converted to 1,25(OH)2D in order to mediate an increase in 
insulin receptor signalling and thus GLUT4 translocation and glucose uptake 
(Thorell et al., 1999). Therefore, differing metabolic rates and processes will 
affect vitamin D metabolism and thus measured systemic 25(OH)D3 
concentrations. 
There are many factors that can influence baseline 25(OH)D3 concentration 
alongside supplementation and thus contribute to the vitamin D status 
measured: diet – intentional and unintentional, occupation, stress, and sunlight 
exposure (i.e. vacations) (Wortsman et al., 2000; Blum et al., 2008; Zgaga et 
al., 2011; Romano et al., 2015) . There were no dietary or activity controls 
during the 6 week period in the current study, although participants were asked 
to maintain their normal habitual diet and lifestyle during the study. However, 
an unintentional change in diet may occur when participating in regular 
exercise due to appetite alterations and caloric expenditure (Klok et al., 2007; 
Deighton et al., 2013; Deighton et al., 2014). 
Additionally, data collection was not carried out during the summer months, 
when exposure to the sun in Scotland is more likely, and so the results do not 
reflect an average annual concentration or consider the seasonal effect.  
 
5.3 Cardiovascular benefits of HIIT  
The development of hypertension, impaired glucose tolerance, and adverse 
lipid profiles are linked to the pathogenesis of T2D (Ferrannini et al., 2005; 
Gastaldelli, 2011). High intensity intermittent training (HIIT) has been 
demonstrated to provide improvements and adaptations in parameters of the 
cardiovascular system (Little et al., 2010; Astorino et al., 2012; Gibala et al., 
2012; Weston et al., 2014). The current study found an increase in absolute 
and relative V̇O2peak and peak power output overall for all participants and the 
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placebo group alone, although not the vitamin D group. This was accompanied 
with a decrease in systolic blood pressure, although interestingly this was 
demonstrated overall for all participants and the vitamin D group, but not the 
placebo group. The current study found a 8.6 % increase in relative V̇O2peak 
after 6 weeks of HIIT, which is similar to other HIIT studies over 2-12 weeks 
that are generally found to be relative to the duration of the training programme 
(Talanian et al., 2007; Racil et al., 2013; Whyte et al., 2010; Adamson et al., 
2014; Gillen et al., 2014; Mancilla et al., 2014), although it should be noted that 
the protocols differ between studies.  
There is a responder/non-responder theory associated with exercise, with 
endurance training and interval training demonstrating differential responses 
and adaptations (Sisson et al., 2009; Scharhag-Rosenberger et al., 2012), with 
an observed heterogeneous response to HIIT (Higgins et al., 2014). This may 
suggest that different exercise models and intensities may provide different 
adaptations and responses on an individual-specific level, which can be 
relevant for underpowered findings. Systolic blood pressure has been shown 
to be influenced by both acute and regular recurrent exercise and vitamin D 
status (Roberts et al., 2002; Tomaschitz et al., 2010; Astorino et al., 2012). 
The association between blood pressure and insulinemia may work in a 
feedback loop mechanism, with a cause and effect relationship between the 
two factors modified by exercise (Roberts et al., 2013).  
Reductions in waist and hip circumference and in the waist-to-hip ratio have 
been found after exercise training interventions (Dunstan et al., 2002; Whyte 
et al., 2010; Mitranun et al., 2014). However, the current study did not observe 
any change in body mass or waist and hip circumference.  
 
5.4 HIIT and vitamin D supplementation on insulin sensitivity 
It was hypothesised that 6 weeks of HIIT would induce an increase in insulin 
sensitivity, likely to be attributed to an improvement in hepatic or skeletal 
muscle insulin-mediated metabolic pathways. An improvement in V̇O2peak has 
been shown to directly and indirectly induce an increase in insulin sensitivity 
through skeletal muscle and hepatic metabolism in overweight and obesity 
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(Mancilla et al., 2014; Cocks et al., 2015). However, the finding that glucose 
tolerance remained unchanged after 6 weeks of HIIT contrasts with other 
studies utilising the same training protocol in overweight and obese adults with 
and without T2D for 2 and 12 weeks, respectively (Little et al., 2011; Mancilla 
et al., 2014). Mechanisms underpinning the improvement in insulin sensitivity, 
such as the protein content of GLUT4, the translocation of GLUT4 in hepatic 
and skeletal muscle cells, and an increase in resting muscle glycogen have 
been demonstrated after only 2 weeks of HIIT using the same protocol (Little 
et al., 2010; Little et al., 2011), however, muscle tissue samples were not 
analysed in the present study. These studies investigated different populations 
compared to the present study: healthy and overweight adults with T2D.  
One of the contributors to the pathogenesis of T2D is chronic hyperglycaemia 
implying that a reduction in fasting glucose could lead to the prevention of a 
dangerously high glucose state (Gastaldelli et al., 2000; Ferrannini et al., 
2005). The current study observed no effect of training on fasting glucose or 
insulin, when combined with 25(OH)D3 supplementation or a placebo. All 
participants had normal fasting glucose and glucose tolerance at baseline, 
therefore an alteration would not necessarily indicate a health benefit. 
Similarly, a decrease in glucose AUC (obtained from the response to an oral 
glucose tolerance test) may not indicate a sign of improved insulin sensitivity 
since the main role of insulin is to regulate glucose homeostasis. A better 
indicator of insulin sensitivity and secretion may be insulin AUC and the 
calculation of whole body insulin sensitivity using Insulin Sensitivity Index 
(Matsuda and DeFronzo, 1999) and HOMA-IR. Although the current study 
observed no effect on insulin sensitivity, calculated using both methods, 
improvements have been reported following investigations using the same 
protocol for only 2 weeks (Hood et al., 2011). 
It has been proposed that diet alone or diet combined with regular exercise are 
stronger determinants of insulin sensitivity rather than exercise alone (Tamura 
et al., 2005; Larson-Meyer et al., 2006). The methodology of the current study 
involved no dietary adjustments other than supplementation with 25(OH)D3.  
It is important to consider the timing of the post-training OGTT as it will 
determine whether the results demonstrate an acute response of the last 
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training session or the chronic adaptation to the training and/or 
supplementation. In the current study, the post-intervention OGTT was 
performed 72 h after the cessation of training and course of 
supplements/placebo to prevent any residual effects of the last HIIT session 
on blood markers. Contrasting methodology has analysed insulin sensitivity 
via an OGTT or the gold standard hyperinsulinemic euglycaemic clamp at 15 
h – 72 h post-training with differing results in indices of insulin sensitivity and 
glucose control (Richards et al., 2010; Whyte et al., 2010). It could also be 
hypothesised that engagement in regular exercise is required to induce the 
acute metabolic response and subsequently maintain the residual effect, as 
opposed to providing chronic adaptations. Studies that have performed the 
post-training OGTT at 24 h after the final HIIT bout may reflect the combined 
impact of acute and chronic exercise training (Rogers, 1989). Therefore, the 
lack of effect on ISI and HOMA-IR in the current study at 72 h post-cessation 
of training could be attributed to the loss of the acute molecular response, 
however Metcalfe et al. (2012) reported an increase in insulin sensitivity when 
the post-OGTT was also performed 72 h after the final training session. 
Conversely, the difference between the response to a 75 g OGTT at 24 h and 
72 h post-training has been demonstrated by Whyte et al. (2010) whereby they 
reported an increase in the Insulin Sensitivity Index after 24 h but the impact 
was lost at 72 h.  
 
5.5 Adiponectin and leptin 
The current study reports an interesting finding: adiponectin concentration was 
unaltered in the vitamin D group alone, but decreased in all participants and 
the placebo group alone. Both exercise and supplementing with 25(OH)D3 
have been shown to upregulate adiponectin concentrations and decrease the 
presence of chronic inflammation. Excessive fat deposition has also been 
associated with a decline in adiponectin concentrations and the development 
of T2D (Kadowaki et al., 2006; Balducci et al., 2010; Chen et al., 2015). 
Therefore, it is hypothesised that adiponectin concentrations will generally be 
lower in overweight and obese individuals than those with a BMI regarded as 
healthy (19-25 kg·m2). Body mass did not change during the 6 week 
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intervention and thus any changes in adiponectin or leptin were not attributed 
to changes in body mass.  
Although the current study did not observe an increase in adiponectin, vitamin 
D3 supplementation alone has been found to induce an increase in adiponectin 
in adolescents and adults with and without T2D (Belenchia et al., 2013; 
Breslavsky et al., 2013). The decline in adiponectin observed in participants 
consuming the placebo may be attributed to unaltered 25(OH)D3 concentration 
and the effect of regular HIIT. Exercise-induced skeletal muscle damage 
frequently occurs following strenuous exercise, specifically HIIT, particularly in 
those unaccustomed to exercise such as an inactive population. The 
mechanical disruption of the contracting fibres in skeletal muscle can initiate 
the inflammatory protein cascade (Pedersen and Hoffman-Goetz, 2000), 
which would in turn could affect the secretion of adiponectin. However, the 
post-OGTT was performed 72 hours after the last HIIT session to avoid the 
acute effects of exercise influencing blood markers. 
The current study found no change in leptin concentration after 6 weeks of 
HIIT with or without 25(OH)D3 supplementation, which is similar to a recent 
supplementation study (Breslavsky et al., 2013). Vitamin D3 supplementation 
alone, even a low dose of 400 IU/day, has been shown to increase leptin 
concentration after 14 weeks, however this was in adults with established 
impaired glucose tolerance (Ghavamzadeh et al., 2014). In contrast, a 
reduction in leptin concentration and the leptin-to-adiponectin ratio was 
reported following 6 months of supplementation with 4000 IU/day in obese 
adults with normal glucose tolerance (Belenchia et al., 2013). The reduction in 
leptin was associated with an elevation in 25(OH)D3 concentration to the 
classified ‘sufficient’ status (Belenchia et al., 2013). As previously discussed, 
alterations in blood markers and insulin sensitivity may only be associated with 
the presence of a ‘sufficient’ vitamin D status (>30 ng·ml-1).  
Independent of vitamin D status, exercise has also been demonstrated to 
affect leptin due to an improvement in V̇O2peak (Bouassida et al., 2010), with 
reductions in leptin observed alongside increases in adiponectin (Trapp et al., 
2008). However, the current study did not induce a reduction in leptin in 
overweight and obese adults despite the increase in V̇O2peak. Interestingly, in 
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light of the attenuation of leptin, Trapp et al. (2008) also reported a reduction 
in insulin resistance and fasting insulin that was accompanied by a decrease 
in total body mass. It could be hypothesised that the lack of alteration of leptin 
in response to HIIT could be due to an unaltered BMI and body mass. 
However, this creates a paradox as an increase in leptin is desired to promote 
a reduction in appetite through the feeling of satiety and thus induce weight 
loss through caloric deficit (Klok et al., 2007; Deighton et al., 2013; Deighton 
et al., 2014). 
 
5.6 Impact on lipid profile and metabolism 
Changes in lipids have independently been associated with improvements in 
insulin sensitivity, with visceral fat deposition and circulating blood triglyceride 
content affecting cell-specific sensitivity to the action of insulin and glucose 
regulation (Larson-Meyer et al., 2006). The present study observed a reduction 
in triglycerides in the group as a whole (n=12). Sprint interval training over 6 
weeks involving 4 Wingates with 4 min recovery periods, has also reported a 
reduction in triglyceride concentration and post-prandial AUC triglyceride 
response following a high fat meal test (Freese et al., 2015). The attenuation 
in triglycerides may be attributed to the higher intensity of the exercise model, 
which induces an up-regulation in lipolysis and thus a clearance in circulating 
triglycerides in the blood (Herd et al., 1985; Herd et al., 2001). Low HDL 
cholesterol concentration and elevated triglyceride concentration is associated 
with insulin resistance, therefore a reduction in triglycerides may favour 
improvements in glucose tolerance and sensitivity to insulin action (Couillard 
et al., 2001). 
 
5.7 Adherence to HIIT 
The protocol was adhered to by all volunteers in the study with positive verbal 
feedback. Despite the study not involving an alternative model of exercise for 
comparison, the 100 % adherence to all 18 training sessions and the 10 
intervals within a single session, suggest that HIIT is a feasible exercise model 
that can be adhered to by an overweight and obese population that habitually 
69 
 
lead an inactive lifestyle. However, all HIIT sessions were performed in a 
laboratory setting under supervision and thus adherence may be attributed to 
a ‘personal training effect’. However, it has been shown that HIIT has been 
adhered to when not supervised by obese adults with pre-diabetes following a 
supervised training phase (Jung et al., 2015). In the latter study the participants 
also received behavioural counselling during the training phase sessions, 
which may have aided autonomy. This preliminary study was successful in 
providing scope for HIIT as an exercise model that can be adhered to over the 
short-term beyond the bounds of a laboratory setting. There has been 
contrasting studies investigating the affective response of exercise intensity on 
adherence and the potential risks involved in specific population groups, i.e. 
obese and elderly (Mediano et al., 2014). The time-efficient attraction of 
interval training (Stutts, 2002) and physiological benefits, alongside adherence 
(Jung et al., 2014; Jung et al., 2015) and enjoyment (Guiraud et al., 2011), 
places HIIT as a form of exercise that has potential to provide health benefits. 
 
5.8 Conclusions 
The findings of the current study demonstrate the effectiveness of HIIT to 
increase peak physical capacity and power output, and induce a reduction in 
systolic blood pressure that could reduce hypertension. These cardiovascular 
benefits were demonstrated following only 6 weeks of HIIT training using the 
relatively short protocol of 10 x 1 min at 89 ± 5 % of HRpeak interspersed with 
1 min active recovery. Although there was no effect of HIIT and 25(OH)D3 
supplementation on insulin sensitivity, there was an observed decrease in 
plasma triglycerides, demonstrating an impact on the lipid profile. Additionally, 
there was an interesting finding in adiponectin in response to the intervention, 
with an overall reduction in all participants and the placebo group but not the 
vitamin D group alone. The combined influence of HIIT and 25(OH)D3 
supplementation on the inflammatory profile and related proteins and 
hormones, including adiponectin and leptin, should be investigated following 
longer exposure to both interventions. The findings from the current study 
reject the hypothesis that HIIT and 25(OH)D3 combined will improve insulin 
sensitivity in overweight and obese males and females, however HIIT alone 
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did induce cardiovascular and metabolic adaptations, although not 
accompanied with an impact on the insulin profile. 
 
5.9 Issues, limitations, and future research 
The current investigation is underpowered and limited by sample size (n=12) 
and it is therefore recommended that larger studies are undertaken in the 
future. Future research should analyse the combined effect of 25(OH)D3 
supplementation and HIIT on the inflammatory profile, specifically proteins and 
hormones involved in the pathogenesis of insulin resistance. In addition to the 
effects on physiological and metabolic parameters, the effect of HIIT and 
25(OH)D3 supplementation should be investigated in relation to hormones that 
mediate satiety and hunger: ghrelin and leptin. A vitamin D supplementation 
group should also be included in future studies to allow further comparison. 
It is important to establish the efficacy of this type of training in an unsupervised 
‘real-world’ scenario. Future studies should investigate adherence to HIIT 
training following an intervention or a ‘training phase’, as utilised by Jung et al. 
(2015), compared to moderate intensity endurance training in an overweight 
and obese population. 
The present study also only included 3 females, which limits the capacity to 
look at gender differences. However, due to hormonal differences between 
genders and evidence of differential beta-cell function and insulin secretion 
rates in females compared to males (Macotela et al., 2009), it is important to 
investigate gender differences in response to both HIIT and 25(OH)D3 
supplementation: combined and independently. In addition, the adaptations to 
different exercise training intensities should be investigated in order to 
recommend exercise protocols specific to gender and thus effectively provide 
health benefits. 
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Appendix 1 A 
 
Physiology Screening Questionnaire 
Please read the following carefully and answer all the questions truthfully. Information 
will be treated with the strictest confidence. 
This is a strictly private confidential document. 
Name:  _____________________________________ 
Date of birth: _______________ 
 
Please delete as appropriate:  
 
Have you ever had a cardiac-related issue such as a heart 
attack, hypertrophic cardiomyopathy, congenital abnormality, 
heart valve defect, heart failure or heart rhythm disturbance? 
 
Have you ever received treatment for a heart problem such as 
heart surgery, the fitting of a pacemaker/defibrillator, coronary 
angioplasty or heart transplantation? 
 
Are you currently taking medication for your heart? 
 
How many units of alcohol do you consume a week? 
N.B One alcohol unit is measured as 10ml or 8g of pure alcohol. This 
equals one 25ml single measure of whisky (ABV 40%), or a third of 
a pint of beer (ABV 5-6%) or half a standard (175ml) glass of red 
wine (ABV 12%). 
 
Do you currently or have you ever suffered from any of the 
following: 
 
Arthritis, osteoporosis or any other bone or joint problem? 
Asthma, bronchitis or any other respiratory problem? 
Coagulation disorders? 
Diabetes (Type I or Type II)? 
Epilepsy? 
Hypertension (High Blood Pressure)? 
Yes/No 
_________ units 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
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Liver or gastrointestinal problems? 
Kidney problems? 
Infectious disease such as HIV, hepatitis or glandular fever? 
Autoimmune disease? 
Any peripheral or central nervous system disease? (e.g. 
Alzheimer’s, Meningitis, Huntington’s, Parkinson’s, 
Tourette’s) 
 
Do you experience any of the following: 
 
Chest discomfort with exertion? 
Unreasonable breathlessness? 
Dizziness, fainting, blackouts? 
Palpitations or skipped heart beats? 
Unusual levels of fatigue? 
 
Please indicate if any of the following are true: 
 
You have a close blood male relative (father or brother) who 
has had a heart attack before the age of 55 or a close female 
relative (mother or sister) who has had a heart attack before 
the age of 65? 
You have elevated levels of cholesterol or are on lipid 
lowering medication? 
You are a cigarette smoker  
You have elevated levels of blood glucose? 
You are completely inactive (do not take part in 20 minutes 
of moderate physical activity such as walking, 3 times per 
week)? 
You have suffered a stroke or major cardiac event? 
You have been bedridden in the past 3 months? 
You have suffered from an infectious disease in last 6 
weeks? 
 
Approximately how many hours in each 24-hour day do you 
usually spend sitting? 
 
Approximately how many hours in each 24-hour day do you 
usually spend watching a screen (i.e. TV, iPad, computer 
monitor) _________ hours 
_________ hours 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
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Are you currently taking any medications? 
If Yes please give details: 
 
 
 
 
Have you any other conditions that may be relevant to an 
individual undertaking strenuous exercise? 
If Yes please give details: 
 
 
 
 
Physical Measurements (to be completed by researcher): 
 
Blood Pressure: ___________________ mmHg 
BMI:   ___________________ kg/m2 
 
Declaration: 
I have understood all of the questions put to me and that my answers are correct to the best 
of my knowledge. I understand that this information will be treated with the strictest 
confidence. 
Name of participant:  _____________________________________ 
Signature of participant: _____________________________________ 
Date:    _________________ 
 
Name of researcher:  _____________________________________ 
Signature of researcher: _____________________________________ 
Date:    _________________ 
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Appendix 1 B  
 
 
Informed Consent Form 
 
TITLE: The combined effect of high intensity intermittent training and vitamin D 
supplementation on insulin sensitivity in overweight and obese males and 
females 
 
Declaration for consent 
 
You have consented to take part in the research study at Edinburgh Napier University, Sighthill 
Campus.  
 
If any of these factors apply please do not sign and give consent to take part in the study. You 
do not have to say which factors apply. 
 Diabetic 
 Current smoker (or a smoker who has quit less that 15 months ago) 
 Use of a tanning bed or undergoing UV light therapy 
 Use of vitamin D supplements or any multivitamins containing vitamin D 
 Known cardiovascular disease or autoimmune diseases 
 Participants who have experienced infectious disease within 6 weeks 
 
I have read and understood the information sheet and this consent form. 
I have had an opportunity to ask questions about my participation. 
I understand that I am under no obligation to take part in this study. 
I understand that I have the right to withdraw from this study at any stage without giving any 
reason. 
I agree to participate in this study. 
 
Name of participant:  _____________________________________ 
Signature of participant: _____________________________________ 
Date:    _________________ 
 
Name of researcher:  _____________________________________ 
Signature of researcher: _____________________________________ 
Date:    _________________ 
 
